References
7
Hukkinen, S.K., Varhe, A., Olkkola, K.T. & Neuvonen, P.J. 1995. Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice. Clinical Pharmacology & Therapeutics 58:127-131.
10
Salive, M.E., Jones, C.A., Guralnik, J.M., Agodoa, L.Y., Pahor, M. & Wallace, R.B. 1995. Serum creatinine levels in older adults: relationship with health status and medications. Age and Ageing 24:142-150.
11
Spring, B., Wurtman, J., Wurtman, R., El-Khoury, A., Goldberg, H., McDermott, J. & Pingitore, R. 1995. Efficacies of dexfenfluramine and fluoxetine in preventing weight gain after smoking cessation. American Journal of Clinical Nutrition 62:1181-1187.
13
Brady, JA., Rock, CL. & Horneffer, MR. 1995. Thiamine status, diuretic medications, and the management of congestive heart failure. Journal of the American Dietetic Association 95:541-544.
14
Loesche, W.J., Bromberg, J., Terpenning, M.S., Bretz, W.A., Dominguez, M.S., Grossman, M.A. & Langmore, S.E. 1995. Xerostomia, xerogenic medications and food avoidances in selected geriatric groups. Journal of the American Geriatric Society 43:401-407.
16
Harris, J.E. 1995. Interaction of dietary factors with oral anticoagulants: review and applications. Journal of the American Dietetic Association 95(5):580-584.
17
Stockigt, J.R. 1996. Drug influences on replacement dosage of thyroxine. Australian Prescriber 19(2):47.
21
Yee, G.C., Stanley, D.L., Pessa, L.J., Costa, T.D., Beltz, S.E., Ruiz, J. & Lowenthal, D.T. 1995. Effect of grapefruit juice on blood cyclosporin concentration. The Lancet 345:955-956.
23
Rousseau, P. & Fuentevilla-Clifton, A. 1993. Acetazolamide and salicylate interaction in the elderly: a case report. Journal of the American Geriatric Society 41(8):868-869.
32
Feher, M.D. & Richmond, W. (Eds.) 1996. Lipids and lipid disorders: second ed. London:Mosby-Wolfe.
44
Roller, L. & Gowan, J. 1998. Interaction with grapefruit juice. Current Therapeutics June:79-82.
46
Yu, CM., Chan, JCN. & Sanderson, JE. 1997. Chinese herbs and warfarin potentiation by "danshen". Journal of Internal Medicine 241:337-339.
47
Fact File 1997. The facts on new antidepressant drugs. Australian Doctor 21 March:26.
48
Bryson, HM. & Benfield, P. 1997. Donepezil. Drugs and Aging 10(3):234-239.
50
Berg, G., Kohlmeier, L. & Brenner, H. 1997. Use of oral contraceptives and serum beta-carotene. European Journal of Clinical Nutrition 51:181-187.
51
Walker, S.E., Shulman, K.I., Tailor, S.A.N. & Gardner, D. 1996. Tyramine content of previously restricted foods in monoamine oxidase inhibitor diets. Journal of Clinical Psychopharmacology 16:383-388.
52
Bennett, WM. 1997. Drug interactions and consequences of sodium restriction. American Journal of Clinical Nutrition 65(Suppl):678S-681S.
55
Vanderpas, J. 1993. Goitrogens and antithyroid compounds. In: Encyclopaedia of food science and nutrition. Vol. IV. (Eds: Macrae, R., Robinson, R.K. & Sadler, M.J.) London:Academic Press 2242-2249.
56
Golik, A., Zaldenstein, R., Dishi, V., Blatt, A., Cohen, N., Cotter, G., Berman, S. & Weissgarten, J. 1998. Effects of captopril and enalapril on zinc metabolism in hypertensive patients. Journal of the American College of Nutrition 17(1):75-78.
57
Strachan, J. & Shepherd, J. 1998. Hyponatraemia associated with the use of selective serotonin re-uptake inhibitors. Australian and New Zealand Journal of Psychiatry 32:295-298.
84
Hurrell, R.F. 1997. Bioavailability of iodine. European Journal of Clinical Nutrition 51 Supplement 1:S9-S12.
85
Olivieri, O., Girelli, D., Stanzial, A.M., Rossi, L., Bassi, A. & Corrocher, R. 1996. Selenium, zinc and thyroid hormones in healthy subjects: low t3/t4 ratio in the elderly is related to impaired selenium status. Biological Trace Element Research 51:31-41.
86
Gaitan, E. 1990. Goitrogens in food and water. Annual Reviews of Nutrition 10:21-39.
90
Stein, J.H. & McBride, P.E. 1998. Hyperhomocysteinemia and atherosclerotic vascular disease. Archives of Internal Medicine 158:1301-1306.
91
Campbell, NRC., Hasinoff, BB., Stalts, H., Rao, B. & Wong, NCW. 1992. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Annals of Internal Medicine 117(12):1010-1013.
97
Marchand, S., Li, J. & Charest, J. 1995. Effects of caffeine on analgesia from transcutaneous electrical nerve stimulation. The New England Journal of Medicine 333(5):325-326.
102
Kim, J.M. & White, R.H. 1996. Effect of vitamin e on the anticoagulant response to warfarin. The American Journal of Cardiology 77:545-546.
105
Palareti, G. & Legnani, C. 1996. Warfarin withdrawal pharmacokinetic-pharmacodynamic considerations. Clinical Pharmacokinetics 30(4):300-313.
106
Yamreudeewong, W., Henann, N.E., Fazio, A., Lower, D. & Cassidy, T.G. 1995. Drug-food interactions in clinical practice. The Journal of Family Practice 40(4):376-384.
107
Pedersen, F.M., Hamberg, O., Hess, K. & Ovesen, L. 1991. The effect of dietary vitamin k on warfarin-induced anticoagulation. Journal of Internal Medicine 229:517-520.
108
Blickstein, D., Shakli, M. & Inbal, A. 1991. Warfarin antagonism by avocado. The Lancet 337(8746):914-915.
109
Paiva, S.A.R., Sepe, T.E., Booth, S.L., Camilo, M.E., O'Brien, M.E., Davidson, K.W., Sadowski, A. & Russell, R.M. 1998. Interaction between vitamin k nutriture and bacterial overgrowth hypochlorhydria induced by omeprazole. American Journal of Clinical Nutrition 68:699-704.
110
Recker, M.W. & Kier, K.L. 1997. Potential interaction between clarithromycin and warfarin. The Annals of Pharmacotherapy 31:996-998.
112
Sinha, R., Rothman, N., Brown, E.D., Mark, S.D., Hoover, R.N., Caporaso, N.E., Levander, O.A., Knize, M.G., Lang, N.P. & Kadlubar, F.F. 1994: Pan-fried meat containing high levels of heterocyclic aromatic amines but low levels of polycyclic aromatic hydrocarbons induces cytochrome p450 1a2 activity in humans. Cancer Research 54:6154-6159.
113
US Department of Agriculture; Agricultural Research Service. 1998. USDA Nutrient Database for Standard Reference, Release 12. Nutrient Data Laboratory Home Page http://www.nal.usda.gov/fnic/foodcomp/Data/.
142
Ravina, A., Slezak, L., Mirsky, N., Bryden, N.A. & Anderson, R.A. 1999. Reversal of corticosteroid-induced diabetes mellitus with supplemental chromium. Diabetic Medicine 16:164-167.
211
Murray, R.K., Granner, D.K., Mayes, P.A. & Rodwell, V.W. (Eds.) 1999. Harper's biochemistry. 25th ed. Stamford:Appleton & Lange.
219
Personal Communication. 1999. Drug administration and enteral feeding/impaired swallow reflex. Drug companies responses regarding my letter of request regarding drug administration and enteral feeds/impaired swallow reflex.
251
ADRAC 1999. Constipation - it can be severe with clozapine. Australian Adverse Drug Reactions Bulletin 18(4):14.
252
Schiffman, S.S., Zervakis, J., Heffron, S. & Heald, A.E. 1999. Effect of protease inhibitors on the sense of taste. Nutrition 15(10):767-772.
254
Gardner, D.M., Shulman, K.I., Walker, S.E. & Tailor, S.A.N. 1996. The making of a user friendly maoi diet. Journal of Clinical Psychiatry 57:99-104.
255
Shulman, K.I. & Walker, S.E. 1999. Refining the maoi diet: tyramine content of pizzas and soy products. Journal of Clinical Psychiatry 60:191-193.
257
Ganguli, R. 1999. Weight gain associated with antipsychotic drugs. Journal of Clinical Psychiatry 60 (Suppl 21):20-24.
258
Gijsbers, B.L.M., Jie, K-S.G. & Vermeer, C. 1996. Effect of food composition on vitamin k absorption in human volunteers. British Journal of Nutrition 76:223-229.
263
Bolin, T., Cowen, A., Korman, M. & Stanton, R. 1998. Dietary fibre & health. Randwick:The Gut Foundation.
266
DiPadova, C., Roine, R., Frezza, M., Gentry, T., Baraona, E. & Lieber, C. 1992. Effects of ranitidine on blood alcohol levels after ethanol ingestion. Journal of the American Medical Association 267(1):83-86.
267
Ortiz, A., Shea, B., Suarez-Almazor, M.E., Moher, D., Wells, G.A. & Tugwell, P. 1998. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis: a meta-analysis of randomized controlled trials. The Journal of Rheumatology 25:36-43.
268
Urdaneta, E., Idoate, I. & Larralde, J. 1998. Drug-nutrient interactions: inhibition of amino acid intestinal absorption by fluoxetine. British Journal of Nutrition 79:439-446.
269
Booth, SL. & Centurelli, MA. 1999. Vitamin k: a practical guide to the dietary management of patients on warfarin. Nutrition Reviews 57(9):288-296.
270
Caspi, D., Lubart, E., Graff, I., Habot, B., Yaron, M. & Segal, R. 2000. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis & Rheumatism 44(1):103-108.
271
McLean, J. & Manchip, S. 1999. Wernicke's encephalopathy induced by magnesium depletion. The Lancet 353:1768.
272
Shimon, I., Almog, S., Vered, Z., Seligmann, H., Shefi, M., Peleg, E., Rosenthal, T., Motro, M., Halkin, H. & Ezra, D. 1995. Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. The American Journal of Medicine 98:485-490.
273
Castro-Gago, M., Eiris-Punal, J., Novo-Rodriguez, MI., Couceiro, J., Camina, F. & Rodriguez-Segade, S. 1998. Serum carnitine levels in epileptic children before and during treatment with valproic acid, carbamazepine, and phenobarbital. Journal of Child Neurology 13:546-549.
274
De Vivo, D.C., Bohan, T.P., Coulter, D.L., Dreifuss, F.E., Greenwood, R.S., Nordli, D.R., Shields, W.D., Stafstrom, C.E. & Tein, I. 1998. L-carnitine supplementation in childhood epilepsy: current perspectives. Epilepsia 39(11):1216-1225.
275
Schulpis, K.H., Karikas, G.A., Tjamouranis, J., Regoutas, S. & Tsakiris, S. 2001. Low serum biotinidase activity in children with valproic acid monotherapy. Epilepsia 42(10):1359-1362.
276
Said, H.M., Redha, R. & Nylander, W. 1989. Biotin transport in the human intestine: inhibition by anticonvulsant drugs. American Journal of Clinical Nutrition 49:127-131.
278
Mydlik, M., Derzsiova, K. & Zemberova, E. 1999. Influence of water and sodium diuresis and furosemide on urinary excretion of vitamin b6, oxalic acid and vitamin c in chronic renal failure. Mineral and Electrolyte Metabolism 25:352-356.
279
Wilcox, C.S. 1999. Do diuretics cause thiamine deficiency? Journal of Laboratory and Clinical Medicine 134:192-193.
280
Rieck, J., Halkin, H., Almog, S., Seligman, H., Lubetsky, A., Olchovsky, D. & Ezra, D. 1999. Urinary loss of thiamine is increased by low doses of furosemide in healthy volunteers. Journal of Laboratory and Clinical Medicine 134:238-243.
281
Suter, P.M. & Vetter, W. 2000. Diuretics and vitamin b1: are diuretics a risk factor for thiamin malnutrition? Nutrition Reviews 58(10):319-323.
282
Bohmer, T. & Suter, PM. 2001. How prevalent is thiamine deficiency in heart failure patients? Nutrition Reviews 59(10):342-344.
283
Bauman, W.., Shaw, S., Jayatilleke, E., Spungen, A.. & Herbert, V. 2000. Increased intake of calcium reverses vitamin b12 malabsorption induced by metformin. Diabetes Care 23(9):1227-1231.
284
Gilligan, M.A. 2002. Metformin and vitamin b12 deficiency. Archives of Internal Medicine 162:484-485.
288
Said, H.M. 1999. Cellular uptake of biotin: mechanisms and regulation. Journal of Nutrition 129:490S-493S.
289
Rathman, S.C., Eisenschenk, S. & McMahon, R.J. 2002. The abundance and function of biotin-dependent enzymes are reduced in rats chronically administered carbamazepine. Journal of Nutrition 132:3405-3410.
290
Ballaban-Gil, K., Callahan, C., O'Dell, C., Pappo, M., Moshe, S. & Shinnar, S. 1998. Complications of the ketogenic diet. Epilepsia 39(7):744-748.
291
Stadler, D.D., Bale, J.F., Chenard, C.A. & Rebouche, C.J. 1999. Effect of long-term valproic acid administration on the efficiency of carnitine reabsorption in humans. Metabolism 48(1):74-79.
292
Ohashi, R., Tamai, I., Yabuuchi, H., Nezu, J-I., Oku, A., Sai, Y., Shimane, M. & Tsuji, A. 1999. Na+-dependent carnitine transport by organic cation transporter (octn2): its pharmacological and toxicological relevance. The Journal of Pharmacology & Experimental Therapeutics 291:778-784.
293
De Vivo, D.C., Bohan, T.P., Konig, S.A., Sugimota, T. & Helton, E. 2002. Effect of l-carnitine treatment for valproate-induced hepatotoxicity. Neurology 58:507-508. Letter to the Editor by author DeVivo, and reply by authors Bohan, Konig, Sugimota & Helton.
294
Sanford, M.G., Ryan, C., Cummings, A.D., Hunt, A., Hackes, B. & Cloud, H.H. 2002. Protocols for identifying drug-nutrient interactions in patients: the role of the dietitian. Journal of the American Dietetic Association; 102(5):729-731. Case report by authors Sanford, Ryan, Cummings, Hunt, Hackes and response by Cloud.
295
French, J.A. & Gidal, B.E. 2000. Antiepileptic drug interactions. Epilepsia 41(Suppl 8):S30-S36.
296
Schwaninger, M., Ringleb, P., Winter, R., Kohl, B., Fiehn, W., Rieser, P.A. & Walter-Sack, I. 1999. Elevated plasma concentrations of homocysteine in antiepileptic drug treatment. Epilepsia 40(3):345-350.
297
Howe, A.M., Lipson, A.H., Sheffield, L.J., Haan, E.A., Halliday, J.L., Jenson, F., David, D.J. & Webster, W.S. 1995. Prenatal exposure to phenytoin, facial development, and a possible role for vitamin k. American Journal of Medical Genetics 58:238-244.
298
Crawford, P. 2001. Epilepsy and pregnancy. Seizure 10:212-219.
299
Verrotti, A., Greco, R., Latini, G., Morgese, G. & Chiarelli, F. 2002. Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia 43(2):1488-1492.
300
Dudeja, P.K., Kode, A., Alnounou, M., Tyagi, S., Torania, S., Subramanian, V.S. & Said, H.M. 2001. Mechanism of folate transport across the human colonic basolateral membrane. American Journal of Physiology - Gastrointestinal & Liver Physiology 281:G54-G60.
301
Karyadi, E., West, C.E., Schultink, W., Nelwan, R.H.H., Gross, R., Amin, Z., Dolmans, W.M.V., Schlebusch, H. & van der Meer, J.W.M. 2002. A double-blind, placebo-controlled study of vitamin a and zinc supplementation in persons with tuberculosis in indonesia: effects on clinical response and nutritional status. American Journal of Clinical Nutrition 75:720-727.
302
Movig, K.L.L., Leufkens, H.G.M., Lenderink, A.W., van den Akker, V.G.A., Hodiamont, P.P.G., Goldschmidt, H.M.J. & Egberts, A.C.G. 2002. Association between antidepressant drug use and hyponatraemia: a case-control study. British Journal of Clinical Pharmacology 53:363-369.
303
Wulffele, M.G., Kooy, A., de Zeeuw, D., Stehouwer, C.D.A. & Gansevoort, R.T. 2002. The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus; a systematic review. British Journal of Clinical Pharmacology 53:549P-550P.
304
Herndon, D.N., Hart, D.W., Wolf, S.E., Chinkes, D.L. & Wolfe, R.R. 2001. Reversal of catabolism by beta-blockade after severe burns. The New England Journal of Medicine 345(17):1223-1229.
305
Gori, T., Burstein, J.M., Ahmed, S., Miner, S.E.S., Al-Hesayen, A., Kelly, S. & Parker, J.D. 2001. Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance. Circulation 104:1119-1123.
329
Winter, R. 1999. A consumer's dictionary of food additives. New York:Three Rivers Press.
331
FSANZ 2003. Food Standards Code Schedule 1. Food Standards Australia & New Zealand (www.foodstandards.gov.au/foodstandardscode/).
332
Suvarna, R., Pirmohamed, M. & Henderson, L. 2003. Possible interaction between warfarin and cranberry juice. British Medical Journal 327(7429):1454.
333
Hadjikoutis, S., Pickersgill, T.P. & Smith, P.E.M. 2003. Weight loss associated with levetiracetam. British Medical Journal 327(7420):905.
334
Akompong, T., Ekso, S., Williamson, K. & Haldar, K. 2000. Gametocytocidal activity and synergistic interactions of riboflavin with standard antimalarial drugs against growth of plasmodium falciparum in vitro. Antimicrobial Agents & Chemotherapy 44(11):3107-3111.
335
Adams, JS., Song, CF. & Kantorovish, V. 1999. Rapid recovery of bone mass in hypercalciuric, osteoporotic men treated with hydrochlorothiazide. Annals of Internal Medicine 130(8):658-660.
336
Schoofs, M.W.C.J., van der Klift, M., Hofman, A., de Laet, C.E.D.H., Herings, R.M.C., Stijnen, T., Pols, H.A.P. & Stricker, B.H.C. 2003. Thiazide diuretics and the risk of hip fracture. Annals of Internal Medicine 139(6):476-482.
337
Cohen, N., Golik, A., Dishi, V., Zaidenstein, R., Weissgarten, J., Averbukh, Z. & Modai, D. 1996. Effect of furosemide oral solution versus furosemide tablets on diureseis and electrolytes in patients with moderate congestive heart failure. Mineral and Electrolyte Metabolism 22:248-252.
338
Fleming, D.J., Jacques, P.F., Massaro, J.M., D'Agostino, R.B.D., Wilson, P.W.F. & Wood, R.J. 2001. Aspirin intake and the use of serum ferritin as a measure of iron status. American Journal of Clinical Nutrition 74:219-226.
339
Leclercq, I., Desager, J-P. & Horsmans, Y. 1998. Inhibition of chlorzoxazone metabolism, a clinical probe for cyp2e1, by a single ingestion of watercress. Clinical Pharmacology & Therapeutics 64(2):144-149.
341
Darbar, D., Fromm, M.F., Dell'Orto, S., Kim, R.B., Kroemer, H.K., Eichelbaum, M. & Roden, D.M. 1998. Modulation by dietary salt of verapamil disposition in humans. Circulation 98:2702-2708.
342
Kim, R.B., Leake, B., Cvetkovic, M., Roden, M.M., Nadeau, J., Walubo, A. & Wilkinson, G.R. 1999. Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity. The Journal of Pharmacology & Experimental Therapeutics 291:1204-1209.
344
Roxanas, M.G. 2003. Mirtazapine-induced hyponatraemia. The Medical Journal of Australia 179(8):453-454. <
345
Howes, L.G. 2002. Hyponatraemia and hypokalaemia caused by indapamide. The Medical Journal of Australia 177:53-54. <
346
McEwen, J. & Marley, J.E. 2002. Hyponatraemia and hypokalaemia caused by indapamide. The Medical Journal of Australia 177:54. <
347
Wilkinson, T.J., Begg, E.J., Winter, A.C. & Sainsbury, R. 1999. Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people. British Journal of Clinical Pharmacology 47:211-217.
348
Kirby, D., Harrigan, S. & Ames, D. 2002. Hyponatraemia in elderly psychiatric patients treated with selective serotonin reuptake inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit. International Journal of Geriatric Psychiatry 17:231-237.
350
Konig, S.A., Knolle, J., Friedewald, S., Koelfen, W., Longin, E., Lenz, T. & Hannak, D. 2003. Effects of valproic acid, carbamazepine, and phenobarbitone on the fatty acid composition of erythrocyte membranes in children. Epilepsia 44(5):708-711.
351
Luef, G.J., Lechleitner, M., Bauer, G., Trinka, E. & Hengster, P. 2003. Valproic acid modulates islet cell insulin secretion: a possible mechanism of weight gain in epilepsy patients. Epilepsy Research 55:53-58.
352
Rathman, S.C., Gregory, J.F. & McMahon, R.J. 2003. Pharmacological biotin supplementation maintains biotin status and function in rats administered dietary carbamazepine. Journal of Nutrition 133:2857-2862.
354
Offman, E.M., Freeman, D.J., Dresser, G.K., Munoz, C., Bend, J.R. & Bailey, D.G. 2001. Red wine-cisapride interaction: comparison with grapefruit juice. Clinical Pharmacology & Therapeutics 70:17-23.
355
Ono, H., Sakamoto, A., Eguchi, T., Fujita, N., Nomura, S., Ueda, H., Sakura, N. & Ueda, K. 1997. Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants. Metabolism 46(8):959-962.
356
Apeland, T., Mansoor, MA., Strandjord, RE. & Kristensen, O. 2000. Homocysteine concentrations and methionine loading in patients on antiepileptic drugs. Acta Neurologica Scandinavica 101:217-223.
357
Apeland, T., Mansoor, MA. & Strandjord, RE. 2001. Antiepileptic drugs as independent predictors of plasma total homocysteine levels. Epilepsy Research 47:27-35.
358
McMahon, R.J. 2002. Biotin in metabolism and molecular biology. Annual Reviews of Nutrition 22:221-239.
359
Kurul, S., Dirik, E. & Iscan, A. 2003. Serum carnitine levels during oxcarbazepine and carbamazepine monotherapies in children with epilepsy. Journal of Child Neurology 18(8):552-554.
361
Cohen, N., Almoznino-Sarafian, D., Alon, I., Gorelik, O., Shteinshnaider, M., Chachashvily, S., Averbukh, Z., Golik, A., Chen-Levy, Z. & Modai, D. 2003. Serum magnesium aberrations in furosemide (frusemide) treated patients with congestive heart failure: pathophysiological correlates and prognostic evaluation. Heart 89:411-416.
363
Douban, S., Brodsky, M.A., Whang, D.D. & Whang, R. 1996. Significance of magnesium in congestive heart failure. American Heart Journal 132(3):664-671.
364
McCabe, B.J., Frankel, E.H. & Wolfe, J.J. 2003. Handbook of food-drug interactions. Boca Raton:CRC Press.
365
Sierra, M., Garcia, J.J., Fernandez, N., Diez, M.J., Calle, A.P. & Farmafibra Group. 2002. Therapeutic effects of psyllium on type 2 diabetic patients. European Journal of Clinical Nutrition 56:830-842.
366
Leier, C.V., Cas, L.D. & Metra, M. 1994. Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. American Heart Journal 128(3):564-574.
367
Ruggenenti, P., Mise, N., Pisoni, R., Arnoldi, F., Pezzotta, A., Perna, A., Cattaneo, D. & Remuzzi, G. 2003. Diverse effects of increasing lisinopril on lipid abnormalities in chronic nephropathies. Circulation 107:586-592.
368
Glauser, T.A. 1999. Topiramate. Epilepsia 40(Suppl. 5):S71-S80.
369
Pinto, J., Huang, Y.P. & Rivlin, R.S. 1981. Inhibition of riboflavin metabolism in rat tissues by chlorpromazine, imipramine, and amitriptyline. Journal of Clinical Investigations 67:1500-1506.
370
Fouty, B., Frerman, F. & Reves, R. 1998. Riboflavin to treat nucleoside analogue-induced lactic acidosis. The Lancet 352:291-292.
371
Luzzati, R., del Bravo, P., di Perri, G., Luzzani, A. & Concia, E. 1999. Riboflavin and severe lactic acidosis. The Lancet 353:901-902.
372
Le Marchand, L., Wilkinson, G.R. & Wilkens, L.R. 1999. Genetic and dietary predictors of cyp2e1 activity: a phenotyping study in hawaii japanese using chlorzoxazone. Cancer Epidemiology, Biomarkers & Prevention 8:495-500.
373
Leclercq, I., Horsmans, Y., Desager, J.P., Pauwels, S. & Geubel, A.P. 1999. Dietary restriction of energy and sugar results in a reduction in human cytochrome p450 2e1 activity. British Journal of Nutrition 82:257-262.
378
Balogh, A., Klinger, G., Henschel, L., Borner, A., Vollanth, R. & Kuhnz, W. 1995. Influence of ethinylestradiol-containing combination oral contraceptives with gestodene or levonorgestrel on caffeine elimination. European Journal of Clinical Pharmacology 48:161-166.
380
Masse, P.G., van den Berg, H., Duguay, C., Beaulieu, G. & Simard, J.M. 1996. Early effect of a low dose (30 ug) ethinyl estradiol-containing triphasil on vitamin b6 status. a follow-up study on six menstrual cycles. International Journal of Vitamin and Nutrition Research 66:46-54.
382
Berger, PB., Herrmann, RR. & Dumesic, DA. 2000. The effect of estrogen replacement therapy on total plasma homocysteine in healthy postmenopausal women. Mayo Clinical Proceedings 75:18-23.
383
Sutterlin, M.W., Bussen, S.S., Rieger, L., Dietl, J. & Steck, T. 2003. Serum folate and vitamin b12 levels in women using modern oral contraceptives (oc) containing 20 ug ethinyl estradiol. European Journal of Obstetrics & Gynecology and Reproductive Biology 107:57-61.
384
Green, T.J., Houghton, L.A., Donovan, U., Gibson, R.S. & O'Connor, D.L. 1998. Oral contraceptives did not affect biochemical folate indexes and homocysteine concentrations in adolescent females. Journal of the American Dietetic Association 98:49-55.
385
Berg, G., Kohlmeier, L. & Brenner, H. 1998. Effect of oral contraceptive progestins on serum copper concentration. European Journal of Clinical Nutrition 52:711-715.
386
Weber, A., Jager, R., Borner, A., Klonger, G., Vollanth, R., Matthey, K. & Balogh, A. 1996. Can grapefruit juice influence ethinylestradiol bioavailability? Contraception 53:41-47.
387
Bailey, DG., Arnold, M. & Spence, D. 1998. Grapefruit juice-drug interactions. British Journal of Clinical Pharmacology 46(2):101-117.
388
Georges, B., Galland, S., Rigault, C., Le Borgne, F. & Demarquoy, J. 2003. Beneficial effects of l-carnitine in myoblastic c2c12 cells: interaction with zidovudine. Biochemical Pharmacology 65:1483-1488.
389
Piscitelli, S.C., Burstein, A.H., Welden, N., Gallicano, K.D. & Falloon, J. 2002. The effect of garlic supplements on the pharmacokinetics of saquinavir. Clinical Infectious Diseases 34:234-238.
390
Brown, BG., Zhao, X-Q., Chait, A., Fisher, LD., Cheung, MC., Morse, JS., Dowdy, AA., Marino, EK., Bolson, EL., Alaupovic, P., Frohlich, J. & Albers, JJ. 2001. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. The New England Journal of Medicine 345(22):1583-1592.
391
Jula, A., Marniemi, J., Huupponen, R., Virtanen, A., Rastas, M. & Ronnemaa, T. 2002. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men. a randomised controlled trial. Journal of the American Medical Association 287(5):598-605.
392
Thomson, F.C., Naysmith, M.R. & Lindsay, A. 2000. Managing drug therapy in patients receiving enteral and parenteral nutrition. Hospital Pharmacist 7(6):155-164.
393
Jetter, A., Kinzig-Schippers, M., Walchner-Bonjean, M., Hering, U., Bulitta, J., Schreiner, P., Sorgel, F. & Fuhr, U. 2002. Effects of grapefruit juice on the pharmacokinetics of sildenafil. Clinical Pharmacology & Therapeutics 71(1):21-29.
394
Sharma, R., Gentry, R.T., Lim, R.T. & Lieber, C.S. 1995. First-pass metabolism of alcohol: absence of diurnal variation and its inhibition by cimetidine after evening meal. Digestive Diseases & Sciences 40(10):2091-2097.
395
Arora, S., Baraona, E. & Lieber, CS. 2000. Alcohol levels are increased in social drinkers receiving ranitidine. American Journal of Gastroenterology 95(1):208-213.
396
Dresser, G.K., Bailey, D.G. & Carruthers, S.G. 2000. Grapefruit juice-felodipine interaction in the elderly. Clinical Pharmacology & Therapeutics 68(1):28-34.
397
Bailey, DG., Dresser, GK., Kreeft, JH., Munoz, C., Freeman, DJ. & Bend, JR. 2000. Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients. Clinical Pharmacology & Therapeutics 68(5):468-477.
398
Malhotra, S., Bailey, D.G., Paine, M.F. & Watkins, P.B. 2001. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins. Clinical Pharmacology & Therapeutics 69(1):14-23.
399
Dresser, G.K., Wacher, V., Wong, S., Wong, H.T. & Bailey, D.G. 2002. Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome p450 3a4 activity in vitro and in vivo. Clinical Pharmacology & Therapeutics 72(3):247-255.
400
Bailey, DG., Dresser, GK. & Bend, JR. 2003. Bergamottin, lime juice, and red wine as inhibitors of cytochrome p450 3a4 activity: comparison with grapefruit juice. Clinical Pharmacology & Therapeutics 73(6):529-537.
402
Tolonen, M., Taipale, M., Viander, B., Pihlava, J-M., Korhonen, H. & Ryhanen, E-L. 2002. Plant-derived biomolecules in fermented cabbage. Journal of Agricultural & Food Chemistry 50(23):6798-6803.
403
Dresser, G.K. & Bailey, D.G. 2003. The effects of fruit juices on drug disposition: a new model for drug interactions. European Journal of Clinical Investigation 33(Suppl 2):10-16.
410
Jensen, O.K., Rasmussen, C., Mollerup, F., Christensen, P.B., Hansen, H., Ekelund, S. & Thulstrup, A.M. 2002. Hyperhomocysteinemia in rheumatoid arthritis: influence of methotrexate treatment and folic acid supplementation. The Journal of Rheumatology 29(8):1615-1618.
411
Furst, D.E. 1995. Practical clinical pharmacology and drug interactions of low-dose methotrexate therapy in rheumatoid arthritis. British Journal of Rheumatology 34(suppl. 2):20-25.
412
Iwamoto, T., Kagawa, Y., Naito, Y., Kuzuhara, S. & Kojima, M. 2004. Steroid-induced diabetes mellitus and related risk factors in patients with neurologic disease. Pharmacotherapy. 24(4):508-514.
414
Schaefer, J.P., Tam, Y., Hasinoff, B.B., Tawfik, S., Peng, Y., Reimche, L. Campbell, N.R.C. 1998. Ferrous sulfate interacts with captopril. British Journal of Clinical Pharmacology 46:377-381.
415
Benvenga, S., Ruggeri, RM., Russo, A., Lapa, D., Campenni, A. & Trimarchi, F. 2001. Usefulness of l-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial. The Journal of Clinical Endocrinology & Metabolism 86(8):3579-3594.
416
Singh, N., Singh, P.N. & Hershman, J.M. 2000. Effect of calcium carbonate on the absorption of levothyroxine. Journal of the American Medical Association 283(21):2822-2825.
417
Aagaard, NK., Andersen, H., Vilstrup, H., Clausen, T. & Jakobsen, J. 2002. Muscle strength, na,k-pumps, magnesium and potassium in patients with alcoholic liver cirrhoses - relation to spironolactone. Journal of Internal Medicine 252:56-63.
418
Ravn, H.B. & Dorup, I. 1997. The concentration of sodium, potassium pumps in chronic obstructive lung disease (cold) patients: the impact of magnesium depletion and steroid treatment. Journal of Internal Medicine 214:23-29.
419
Laine, J. & Holmberg, C. 1996. Mechanisms of hyperuricemia in cyclosporine-treated renal transplanted children. Nephron 74:318-323.
420
Lajer, H., Bundgaard, H., Secher, N.H., Hansen, H.H., Kjeldsen, K. & Daugaard, G. 2003. Severe intracellular magnesium and potassium depletion in patients after treatment with cisplatin. British Journal of Cancer 89(9):1633-1637.
421
Jeeja, M.C., Jayakrishnan, T., Narayanan, P.V., Kumar, M.S.V., Thejus, T. & Anilakumari, V.P. 2013. Folic acid supplementation on homocysteine levels in children taking antiepileptic drugs: a randomized controlled trial. Journal of Pharmacology & Pharmacotherapeutics 5(2):93-99.
422
Jansen, G., van der Heijden, J., Oerlemans, R., Lems, W.F., Ifergan, I., Scheper, R.J., Assaraf, Y.G. & Dijkmans, B.A.C. 2004. Sulfasalazine is a potent inhibitor of the reduced folate carrier. Arthritis & Rheumatism 50(7):2130-2139.
423
Zaidenstein, R., Sovack, S., Gips, M., Avni, B., Dishi, V., Weissgarten, Y., Golik, A. & Scapa, E. 2001. Effect of grapefruit juice on pharmacokinetics of losartan and its active metabolite e3174 in healthy volunteers. Therapeutic Drug Monitoring 23(4):369-373.
424
Gubbins, P.O., McConnell, S.A., Gurley, B.J., Fincher, T.K., Franks, A.M., Williams, D.K., Penzak, S.R. & Saccente, M. 2004. Influence of grapefruit juice on the systemic availability of itraconazole oral solution in healthy adult volunteers. Pharmacotherapy 24(4):460-467.
425
Bard, RL., Bleske, BE. & Nicklas, JM. 2004. Food: an unrecognised source of loop diuretic resistance. Pharmacotherapy 24(5):630-637.
426
Sica, D.A. 2004. Diuretic-related side effects: development and treatment. The Journal of Clinical Hypertension 6(9):532-540.
427
Bellou, A., Aimone-Gastin, I., de Korwin, J-D., Bronowicki, J-P., Moneret-Vautrin, A., Nicolas, J-P., Bigard, M-A. & Gueant, J-L. 1996. Cobalamin deficiency with megaloblastic anaemia in one patient under long-term omeprazole therapy. Journal of Internal Medicine 240:161-164.
428
Deshmukh, R. & Franco, K. 2003. Managing weight gain as a side effect of antidepressant therapy. Cleveland Clinic Journal of Medicine 70(7):614-623.
429
Sica, D.A. 2004. Angiotensin-converting enzyme inhibitors side effects - physiologic and non-physiologic considerations. The Journal of Clinical Hypertension 6(7):410-416.
430
Ranta, A. & Wooten, G.F. 2004. Hyponatraemia due to an additive effect of carbamazepine and thiazide diuretics. Epilepsia 45(7):879.
431
Fabian, T.J., Amico, J.A., Kroboth, P.D., Mulsant, B.H., Corey, S.E., Begley, A.E., Bensasi, S.G., Weber, E., Dew, M.A., Reynolds, C.F. & Pollock, B.G. 2004. Paroxetine-induced hyponatremia in older adults. Archives of Internal Medicine 164:327-332.
434
Dorup, I., Skajaa, K. & Thybo, N.K. 1993. Oral magnesium supplementation restores the concentrations of magnesium, potassium and sodium-potassium pumps in skeletal muscle of patients receiving diuretic treatment. Journal of Internal Medicine 233:117-123.
435
Parker, R.B., Yates, C.R., Soberman, J.E. & Laizure, S.C. 2003. Effects of grapefruit juice on intestinal p-glycoprotein: evaluation using digoxin in humans. Pharmacotherapy 23(8):979-987.
436
Sharma, V.R., Brannon, M.A. & Carloss, E.A. 2004. Case report: effect of omeprazole on oral iron replacement in patients with iron deficiency anemia. Southern Medical Journal 97(9):887-889.
437
Sweetman, S.C., Blake, P.S., McGlashan, J.M., Neathercoat, G.C., Parsons, A.V., Bosede, O.A., Brayfield, A., Cadart, C.R.M., Eager, K., Gotecha, P., Handy, S.L., Ho, S.W., Kivell, B.H., Lee, V.A., Riley, K.S., Sheridan, L.M., Sutton, S. & Viedge, G.W. 2005. Martindale: the complete drug reference. London:Pharmaceutical Press.
438
Donohoo, E., Harvey, A., Jarvis, J., Bidgood, M., Westcott, H., Keen, S. & Hoa, V. 2006. June 2006 mims annual. St Leonards:CMPMedica.
439
Swain, A.R., Soutter, V.L. & Loblay, R.H. 2002. Friendly food recipes for life. Sydney:Murdoch.
440
Donohoo, E., Harvey, A., Jarvis, J., Bidgood, M., Westcott, H., Keen, S., Hoa, V., Morgan, E. & Hunter, S. 2007. June 2007 mims annual. St Leonards:CMPMedica.
441
Donohoo, E., Hoa, V., Harvey, A., Morgan, E., Westcott, H., Komarek, L., Bidgood, M., Gunewardhane, N., Keen, S. & Hunter, S. 2008. June 2008 mims annual. St Leonards:CMPMedica.
442
Drug Companies. 2009. Drug companies responses to letter requesting excipient information.
443
www.medicines.org.au
444
Epstein, M., McGrath, S. & Law, F. 2006. Proton-pump inhibitors and hypomagnesemic hypoparathyroidism. The New England Journal of Medicine 355(17):1834-1836.
445
Kontorinis, N. & Dieterich, D. 2003. Hepatoxicity of antiretroviral therapy. AIDS Review 5:36-43.
446
Carr, A., Samaras, K., Burton, S., Law, M., Freund, J., Chisholm, D.J. & Cooper, A.C. 1998. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving hiv protease inhibitors. AIDS 12(7):F51-F58.
447
Moreyra, A.E., Wilson, A.C. & Koraym, A. 2005. Effect of combining psyllium fiber with simvastatin in lowering cholesterol. Archives of Internal Medicine 165:1161-1166.
448
Centanni, M., Gargano, L., Canettieri, G., Viceconti, N., Franchi, A., Delle Fave, G. & Annivale, B. 2006. Thyroxine in goiter, helicobacter pylori infection, and chronic gastritis. The New England Journal of Medicine 354(17):1787-1797.
450
Elphick, D.A., Chew, T.S., Higham, S.E., Bird, N., Ahmad, A. & Sanders, D.S. 2005. Small bowel bacterial overgrowth in symptomatic older people: can it be diagnosed earlier? Gerontology 51:396-401.
451
Brown, TT., Cole, SR., Li, X., Kingsley, LA., Palella, FJ., Riddler, SA., Visscher, BR., Margolick, JB. & Dobs, AS. 2005. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicentre aids cohort study. Archives of Internal Medicine 165:1179-1184.
453
Spiller, R. 2008. Review article: probiotics and prebiotics in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 28:385-396.
454
Scholl, I., Untersmayr, E., Bakos, N., Roth-Walter, F., Gleis, A., Boltz-Nitulescu, G., Scheiner, O. & Jensen-Jarolim, E. 2005. Antiulcer drugs promote oral sensitization and hypersensitivity to hazelnut allergens in balb/c mice and humans. American Journal of Clinical Nutrition 81:154-60.
455
Roberts, G.W. 2004. Taking care of thyroxine. Australian Prescriber 27(3):75-76.
456
Foster, B.J., Shults, J., Zemel, B.S. & Leonard, M.B. 2004. Interactions between growth and body composition in children treated with high-dose chronic glucocorticoids. American Journal of Clinical Nutrition 80:1334-1341.
457
ADRAC 2004. Atypical antipsychotics and hyperglycaemia. Australian Adverse Drug Reactions Bulletin 23(3):11.
458
Henderson, D.C., Cagliero, E., Copeland, P.M., Borba, C.P., Evins, E., Hayden, D., Weber, M.T., Anderson, E.J., Allison, D.B., Daley, T.B., Schoenfeld, D. & Goff, D.C. 2005. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents. Archives of General Psychiatry 62:19-28.
459
Ribeiro-Alves, M.A., Trugo, L.C. & Donangelo, C.M. 2003. Use of oral contraceptives blunts the calciuric effect of caffeine in young adult women. Journal of Nutrition 133(2):393-398.
460
Kordas, K. & Stoltzfus, R.J. 2004. New evidence of iron and zinc interplay at the enterocyte and neural tissues. Journal of Nutrition 134:1295-1298.
461
Graham, T.E., Sathasivam, P., Rowland, M., Marko, N., Greer, F. & Battram, D. 2001. Caffeine ingestion elevates plasma insulin response in humans during an oral glucose tolerance test. Canadian Journal of Physiology & Pharmacology 79:559-565.
462
Robinson, L.E., Savani, S., Battram, D.S., McLaren, D.H., Sathasivan, P. & Graham, T.E. 2004. Caffeine ingestion before an oral glucose tolerance test impairs blood glucose management in men with type 2 diabetes. Journal of Nutrition 134:2528-2533.
463
Clayton, JA., Rodgers, S., Blakey, J., Avery, A. & Hall, IP. 2005. Thiazide diuretic prescription and electrolyte abnormalites in primary care. British Journal of Clinical Pharmacology 61(1):87-95.
464
Lander, C.M. 2008. Antiepileptic drugs in pregnancy and lactation. Australian Prescriber 31(3):70-72.
465
New drugs. 2008. Duloxetine. Australian Prescriber 31(3):80-81.
466
Dresser, G.K., Bailey, D.G., Leake, B.F., Schwarz, U.I., Dawson, P.A., Freeman, D.J. & Kim, R.B. 2002. Fruit juices inhibit organic anion transporting polypepetide-mediated drug uptake to decrease the oral availability of fexofenadine. Clinical Pharmacology & Therapeutics 71:11-20.
467
Ortiz, Z., Shea, B., Suarez-Almazor, M.E., Moher, D., Wells, G.A. & Tugwell, P. 1999. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database of Systematic Reviews 4. Art. No: CD000951.
468
Valsamis, H.A., Arora, S.K., Labban, B. & McFarlan, S.I. 2006. Antiepileptic drugs and bone metabolism. Nutrition & Metabolism 3:36-46.
469
Visser, K., Katchamart, W., Loza, E., Martinez-Lopez, J.A., Salliot, C., Trudeau, J., Bombardier, C., Carmona, L., van der Heijde, D., Bijlsma, J.W.J., Boumpas, D.T., Canhao, H., Edwards, C.J., Hamuryudan, V., Kvien, T.K., Leeb, B.F., Martin-Mola, E.M., Mielants, H., Muller-Ladner, U., Murphy, G., Ostergaard, M., Pereira, I.A., Ramos-Remus, C., Valentini, G., Zochling, J. & Dougados, M. 2009. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3e initiative. Annals of the Rheumatic Diseases 68:1086-1093.
470
Nzila, A., Mberu, E., Bray, P., Kokwaro, G., Winstanley, P., Marsh, K. & Ward, S. 2003. Chemosensitization of plasmodium falciparum by probenecid in vitro. Antimicrobial Agents & Chemotherapy 47(7):2108-2112.
471
Ranganathan, L.N. & Ramaratnam, S. 2009. Vitamins for epilepsy (review). Cochrane Database of Systematic Reviews, Issue 2.
472
Chin, TWF., Loeb, M. & Fong, IW. 1995. Effects of an acidic beverage (coca-cola) on absorption of ketoconazole. Antimicrobial Agents & Chemotherapy 39(8):1671-1675.
473
Black, CA. & Fraser, CM. 1999. Iron deficiency anaemia and aspirin use in old age. British Journal of General Practice 49:729-730.
474
von Bahr, C., Ursing, C., Yasui, N., Tybring, G., Bertilsson, L. & Rojdmark, S. 2000. Fluvoxamine but not citalopram increases serum melatonin in healthy subjects - an indication that cytochrome p450 cyp1a2 and cyp 2c19 hydroxylate melatonin. European Journal of Clinical Pharmacology 56:123-127.
475
Facciola, G., Hidestrand, M., von Bahr, C. & Tybring, G. 2001. Cytochrome p450 isoforms involved in melatonin metabolism in human liver microsomes. European Journal of Clinical Pharmacology 56:881-888.
476
Peloquin, C.A., Namdar, R. & Singleton, M.D. 1999. Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids. Chest 115:12-18.
477
Bartle, WR., Madorin, P. & Ferland, G. 2001. Seaweed, vitamin k, and warfarin. American Journal of Health-system Pharmacy 58:2300.
478
Wen, X., Wang, J-S., Neuvonen, P.J. & Backman, J.T. 2002. Isoniazid is a mechanism-based inhibitor of cytochrome p450 1a2, 2a6, 2c19 and 3a4 isoforms in human liver microsomes. European Journal of Clinical Pharmacology 57:799-804.
479
Miki, M., Ishikawa, T. & Okayama, H. 2005. An outbreak of histamine poisoning after ingestion of the ground saury paste in eight patients taking isoniazid in tuberculous ward. Internal Medicine 44:1133-1136.
480
Slain, D., Amsden, J.R., Khakoo, R.A., Fisher, M.A., Lalka, D. & Hobbs, G.R. 2005. Effect of high-dose vitamin c on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers. Pharmacotherapy 25(2):165-170.
481
Rieu, I., Sornet, C., Grizard, J. & Dardevet, D. 2004. Glucocorticoid excess induces a prolonged leucine resistance on muscle protein synthesis in old rats. Experimental Gerontology 39:1315-1321.
482
Genser, D. 2008. Food and drug interaction: consequences for the nutrition/health status. Annals of Nutrition & Metabolism 52(suppl 1):29-32.
483
Martino, E., Bartalena, L., Bogazzi, F. & Braverman, L.E. 2001. The effects of amiodarone on the thyroid. Endocrine Reviews 22(2):240-254.
484
Libersa, C.C., Brique, S.A., Motte, K.B., Caron, J.F., Guedon-Moreau, L.M., Humbert, L., Vincent, A., Devos, P. & Lhermitte, M.A. 2000. Dramatic inhibition of amiodarone metabolism induced by grapefruit juice. British Journal of Clinical Pharmacology 49:373-378.
485
Wu, S-P., Shyu, M-K., Liou, H-H., Gau, C-S, & Lin, C-J. 2004. Interaction between anticonvulsants and human placental carnitine transporter. Epilepsia 45(3):204-210.
486
Caffeine. www.foodstandards.gov.au/foodmatters/caffeine/index.cfm
487
Reiter, R.J., Manchester, L.C. & Tan, D-X. 2005. Melatonin in walnuts: influence on levels of melatonin and total antioxidant capacity of blood. Nutrition 21(9):920-924.
488
Maldonado, M.D., Moreno, H. & Calvo, J.R. 2009. Melatonin present in beer contributes to increase the levels of melatonin and antioxidant capacity of the human serum. Clinical Nutrition 28:188-191.
489
Burkhardt, S., Tan, DT., Manchester, LC., Hardeland, R. & Reiter, RJ. 2001. Detection and quantification of the antioxidant melatonin in montmorency and balataon tart cherries (prunus cerasus). Journal of Agricultural and Food Chemistry 49:4898-4902.
490
Reiter, R.J., Tan, D.T., Burkhardt, S. & Manchester, L.C. 2001. Melatonin in plants. Nutrition Reviews 59(9):286-290.
491
FSANZ. 2008. Final assessment report. Proposal P279: review of schedule 1 and related clauses standard 1.3.1 - food additives.
492
Kema, I.P., Schellings, A.M.J., Melborg, G., Hoppenbrouwers, C.J.M. & Muskiet, F.A.J. 1992. Influence of serotonin- and dopamine-rich diet on platelet serotonin content and urinary excretion of biogenic amines and their metabolites. Clinical Chemistry 38(9):1730-1736.
493
Watanabe, H., Kakihana, M., Ohtsuka, S. & Sugishita, Y. 1997. Randomized, double-blind, placebo-controlled study of supplemental vitamin e on attenuation of the development of nitrate tolerance. Circulation 96:2545-2550.
494
Bassenge, E., Fink, N., Skatchkov, M. & Fink, B. 1998. Dietary supplement with vitamin c prevents nitrate tolerance. The Journal of Clinical Investigation 102(1):67-71.
495
Watanabe, H., Kakihana, M., Ohtsuka, S. & Sugishita, Y. 1998. Randomized, double-blind, placebo-controlled study of ascorbate on the preventive effect of nitrate tolerance in patients with congestive heart failure. Circulation 97:886-891.
496
Maintz, L. & Novak, K. 2007. Histamine and histamine intolerance. American Journal of Clinical Nutrition 85:1185-1196.
497
Helferich, W. & Winter, C.K. 2001. Food toxicology. Boca Raton:CRC Press.
498
Remer, T. & Manz, F. 1995. Potential renal acid load of foods and its influence on urine pH. Journal of the American Dietetic Association 95:791-797.
499
Kohlmeier, M. 2003. Nutrient metabolism. Amsterdam:Academic Press.
500
US Department of Agriculture; Agricultural Research Service. 2005. USDA National Nutrient Database for Standard Reference, Release 18. Nutrient Data Laboratory Home Page http://www.nal.usda.gov/fnic/foodcomp.
501
Donohoo, E., Hoa, V., Harvey, A., Morgan, E., Westcott, H., Komarek, L., Bidgood, M., Gunewardhane, N., Keen, S. & Hunter, S. 2008. eMIMS 2008.Sydney:CMPMedica Australia.
502
Mannovola, D., Coco, P., Vannucchi, G., Bertuelli, R., Carletto, M., Casali, P., Beck-Peccoz, P. & Fugazzola, L. 2007. A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake. The Journal of Clinical Endocrinology & Metabolism 92(9):3531-3534.
503
Ling, B. & Alcorn, J. 2008. Acute administration of cefepime lowers l-carnitine concentrations in early lactation stage rat milk. The Journal of Nutrition 138:1317-1322.
504
Donohoo, E., Hoa, V., Bidgood, M., Botros, S., Gunewardhane, N., Harvey, A., Hunter, S., Keen, S., Komarek, L. & Morgan, E. 2009. June 2009 mims annual. St Leonards:CMPMedica.
505
Hanselin, M. 2010. INR elevation with maitake extract in combination with warfarin. The Annals of Pharmacotherapy 44(1):223-224.
506
Werner, T., Treiss, I., Kohlmueller, D., Mehlem, P., Teich, M., Longin, E., Gerstner, T., Koenig, S.A. & Schulze, A. 2007. Effects of valporate on acylcarnitines in children with epilepsy using esi-ms/ms. Epilepsia 48(1):72-76.
507
Gelisse, P., Juantas-Morales, R., Genton, P., Hillaire-Buys, D., Diaz, O., Coubes, P. & Crespel, A. 2008. Dramatic weight loss with levetiracetam. Epilepsia 49(2):308-315.
508
Gerber, J.G., Kitch, D.W., Fichtenbaum, C.J., Zackin, R.A., Charles, S., Hogg, E., Acosta, E.P., Connick, E., Wohl, D., Kojic, E.M., Benson, C.A. & Aberg, J.A. 2008. Fish oil and fenofibrate for the treatment of hypertriglyceridemia in hiv-infected subjects on antiretoroviral therapy. Journal of Acquired Immune Deficiency Syndrome 47(4):459-466.
509
Rush, D.N., Jones, M.W., Futrell, D.P., Futrell, W.R., McDowell, J.O. & Ferreri, S.P. 2007. Evaluation of calcium and vitamin d supplementation in bisphosphonate therapy. Journal of the American Pharmacists Association 47(6):725-728.
510
Tsuruoka, S., Wakaumi, M., Nishiki, K., Araki, N., Harada, K., Sugimoto, K. & Fujimura, A. 2004. Subclinical alteration of taste sensitivity induced by candesartan in healthy subjects. British Journal of Clinical Pharmacology 57(6):807-812.
511
Heeringa, M. 1998. Reversible dysgeusia attributed to losartan. Annals of Internal Medicine 129(1):72.
512
Famularo, G., Gasbarrone, L., De Virgilio, A. & Minisola, G. 2009. Mirtazipine-associated hyponatraemia in an elderly patient. The Annals of Pharmacotherapy 43:1144-1145.
513
Colquhoun, DM., Jackson, R., Walters, M., Hicks, BJ., Goldsmith, J., Young, P., Strakosch, C. & Kostner, KM. 2005. Effects of simvastatin on blood lipids, vitamin e, coenzyme q10 levels and left ventricular function in humans. European Journal of Clinical Investigation 35:251-258.
514
Vogt, J.A., Ishii-Schrade, K.B., Pencharz, P.B., Jones, P.J.H. & Wolever, T.M.S. 2006. L-rhamnose and lactulose decrease serum triacylglycerols and their rates of synthesis, but do not affect serum cholesterol concentrations in men. The Journal of Nutrition 136(8):2160-2166.
515
Martin, J., Wang, Z.Q., Zhang, X.H., Wachtel, D., Volaufova, J., Matthews, D.E. & Cefalu, W.T. 2006. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care 29:1826-1832.
516
Chan, DC., Watts, GF., Nguyen, MN. & Barrett, PHR. 2006. Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of hdl apolipoproteins a-1 and a-11 in men with abdominal obesity. American Journal of Clinical Nutrition 84:37-43.
517
Ting, R.Z-W., Szeto, C.C., Chan, M.H-M., Ma, K.K. & Chow, K.M. 2006. Risk factors of vitamin b12 deficiency in patients receiving metformin. Archives of Internal Medicine 166:1975-1979.
518
Liu, K.W., Dai, L.K. & Jean, W. 2006. Metformin-related vitamin b12 deficiency. Age and Ageing 35:200-201.
519
Morris, C. & Pillans, P. 2017. Proton pump inhibitor-associated hypomagnesaemia and hypocalcaemia. Australian Prescriber 40:79-80.
520
Campbell, PMF. & Allain, TJ. 2006. Amiodarone, sunlight avoidance and vitamin d deficiency. British Journal of Cardiology 13(6):430-431.
521
Pohle, T., Brzozowski, T., Becker, J.C., van der Voort, I.R., Markmann, A., Konturek, S.J., Moniczewski, A., Domschke, W. & Konturek, J.W. 2001. Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: gastroprotection by vitamin c. Alimentary Pharmacology Therapeutics 15:677-687.
522
Ratain, M.J. & Cohen, E.E. 2007. The value meal: how to save $1,700 per month or more on lapatinib. Journal of Clinical Oncology 25(23):3397-3398.
523
Lin, C-C. & Yin, M-C. 2009. Vitamins b depletion, lower iron status and decreased antioxidative defence in patients with chronic hepatitis c treated by pegylated interferon alfa and ribavirin. Clinical Nutrition 28:34-38.
524
Mintzer, S., Boppana, P., Toguri, J. & DeSantis, A. 2006. Vitamin d levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia 47(3):510-515.
525
The DREAM Trial Investigators. 2006. Effect of ramipril on the incidence of diabetes. The New England Journal of Medicine 355(15):1551-1562.
526
Burt, MG., Johannsson, G., Umpleby, M., Chisholm, DJ. & Ho, KJY. 2007. Impact of acute and chronic low-dose glucocorticoids on protein metabolism. Journal of Clinical Endocrinology & Metabolism 92:3923-3929.
527
Miller, M. 2006. Hyponatremia and arginine vasopressin dysregulation: mechanisms, clinical consequences, and management. Journal of General Internal Medicine 54(2):345-353.
528
Butner, LE., Fulcon, PP. & Feldman, G. 2000. Calcium carbonate-induced hypothyroidism. Annals of Internal Medicine 132(7):595.
529
Parker, D.L., Hoffman, T.K., Tucker, M.A. & Meier, D.J. 2009. Interaction between warfarin and black tea. The Annals of Pharmacotherapy 43:150-151.
530
Hornsby, L.B., Hester, E.K. & Donaldson, A.R. 2008. Potential interaction between warfarin and high dietary protein intake. Pharmacotherapy 28(4):536-539.
531
Untersmayr, E., Scholl, I., Swoboda, I., Beil, W.J., Forster-Waldl, E., Walter, F., Riemer, A., Kraml, G., Kinaciyan, T., Spitzauer, S., Boltz-Nitulescu, G., Scheiner, O. & Jensen-Jarolim, E. 2003. Antacid medication inhibits digestion of dietary proteins and causes food allergy: a fish allergy model in balb/c mice. Journal of Allergy and Clinical Immunology 112:616-623.
532
Pylvanen, V., Pakarinen, A., Knip, M. & Isojarvi, J. 2006. Characterization of insulin secretion in valproate-treated patients with epilepsy. Epilepsia 47(9):1460-1464.
533
Romanoff, R.L., Ross, D.M. & McMartin, K.E. 2007. Acute ethanol exposure inhibits renal folate transport, but repeated exposure upregulates folate transport proteins in rats and human cells. The Journal of Nutrition 137:1260-1265.
534
Tuntipopipat, S., Judprasong, K., Zeder, C., Wasantwisut, E., Winichagoon, P., Charoenkiatkul, S., Hurrell, R. & Walczyk, T. 2006. Chili, but not turmeric, inhibits iron absorption in young women from an iron-fortified composite meal. The Journal of Nutrition 136:2970-2974.
535
Yang, Y-X., Lewis, J.D., Epstein, S. & Metz, D.C. 2006. Long-term proton pump inhibitor therapy and risk of hip fracture. Journal of the American Medical Association 296(24):2947-2953.
536
Elimrani, I., Lahjouji, K., Seidman, E., Roy, M-J., Mitchell, G.A. & Qureshi, I. 2003. Expression and localization of organic cation/carnitine transporter octn2 in caco-2 cells. American Journal of Physiology - Gastrointestinal & Liver Physiology 284:G863-871.
537
Veeramachaneni, S., Ausman, L.M., Choi, S.W., Russell, R.M. & Wang, X-D. 2008. High dose lycopene supplementation increases hepatic cytochrome p450 2e1 protein and inflammation in alcohol-fed rats. The Journal of Nutrition 138:1329-1335.
538
Carter, AA., Gomes, T., Camacho, X., Juurlink, DN., Shah, BR. & Mamdani, MM. 2013. Risk of incident diabetes among patients treated with statins: population based study. BMJ 346:2610-2621.
539
Swannick, G., Hoa, V., Bidgood, M., Cheng, S., Death, R., dela Pena, A., FitzGerald, V., Georges, J., Gunewardhane, N., Harvey, A. Keen, S. 2012. june 2012 mims annual . St Leonards:UBM Medica Australia
540
Kappers, M.H.W., van Esch, J.H.M., Smedts, F.M.M., de Krijger, R.R., Mathijssen, R.H.J., Sleijfer, S., Leijten, F., Danse, A.H.J., van den Meiracker, A.H. & Visse, T.J. 2011. Sunitinib-induced hypothyroidism is due to induction of type 3 deiodinase activity and thyroidal capillary regression. Journal of Clinical Endocrinology & Metabolism 96:3087-3094.
541
de Jager, J., Kooy, A., Lehert, P., Wulffele, M.G., van der Kolk, J., Bets, D., Verburg, J., Donker, A.J.M. & Stehouwer, C.D.A. 2010. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin b-12 deficiency: randomised placebo controlled trial. British Medical Journal 340:c2181-2188.
542
Sahu, J.K., Gulati, S., Kabra, M., Arya, R., Sharma, R., Gupta. M., Kaleekal, T., Reeta, K. & Gupta, Y.K. 2012. Evaluation of subclinical hypothyroidism in ambulatory children with controlled epilepsy on valproate monotherapy. Journal of Child Neurology 27(5):594-597.
543
Burt, MG., Roberts, GW., Aguilar-Loza, NR., Frith, P. & Stranks, SN. 2011. Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for copd. Journal of Clinical Endocrinology & Metabolism 96(6):1789-1796.
544
Samojlik, I., Petkovic, S., Mimica-Dukic, N. & Bozin, B. 2012. Acute and chronic pretreatment with essential oil of peppermint (mentha x piperita l., lamiaceae) influences drug effects. Phytotherapy Research 26:820-825.
545
Verrotti, A., Scaparrotta, A., Agostinelli, S., di Pillo, S., Chiarelli, F. & Grosso, S. 2011. Topiramate-induced weight loss: a review. Epilepsy Research 95:189-199.
546
Krishna, G., Moton, A., Ma, L., Medlock, M.M. & McLeod, J. 2009. Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers. Antimicrobial Agents & Chemotherapy 53(3):958-966.
547
Yang, C.Y., Chao, P.D.L., Hou, Y.C., Tsai, S.Y., Wen, K.C. & Hsiu, S.L. 2006. Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats. Food & Chemical Toxicology 44:1572-1578.
548
Wong, T., Girgis, C.M., Ngu, M.C., Chen, R.C.Y., Emmett, L., Archer, K.A. & Seibel, M.J. 2010. Hypophosphatemic osteomalacia after low-dose adefovir dipivoxil therapy for hepatitis b. Journal of Clinical Endocrine Metabolism 95(2):479-480.
549
Gaitan, D., Flores, S., Saavedra, P., Miranda, C., Olivares, M., Arredondo, M., de Romana, D.L., Lonnerdal, B. & Pizarro, F. 2011. Calcium does not inhibit the absorption of 5 milligrams of nonheme or heme iron at doses less than 800 milligrams in nonpregnant women. The Journal of Nutrition 141:1652-1656.
550
Zanchi, A., Pechere-Bertschi, A., Burnier, M. & Bonny, O. 2011. Effects of pioglitazone on renal calcium excretion. Journal of Clinical Endocrinology & Metabolism 96(9):E1482-1485.
551
Schafer, A.L., Sellmeyer, D.E., Schwartz, A.V., Rosen, C.J., Vittinghoff, E., Palermo, L., Bilezikian, J.P., Shoback, D.M. & Black, D.M. 2011. Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyriod hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the path study). Journal of Clinical Endocrinology & Metabolism 96(12):E1982-1989.
552
Bailey, DG. 2010. Fruit juice inhibition of uptake transport: a new type of food-drug interaction. British Journal of Clinical Pharmacology 70(5):645-655.
553
Monterrey-Rodriguez, J. 2002. Interaction between warfarin and mango fruit. The Annals of Pharmacotherapy 36:940-941.
554
Hamann, G.L., Campbell, J.D. & George, C.M. 2011. Warfarin-cranberry juice interaction. The Annals of Pharmacotherapy 45:e17.
555
Beatty, SJ., Mehta, BH. & Rodis, JL. 2005. Decreased warfarin effect after initiation of high-protein, low-carbohydrate diets. The Annals of Pharmacotherapy 39:744-747.
556
Sawynok, J. & Reid, A.R. 2012. Caffeine inhibits antinociception by acetaminophen in the formalin test by inhibiting spinal adenosine a1 receptors. European Journal of Pharmacology 674:248-254.
557
Tripathi, A., PremKumar, K.V., Pandey, A.N., Khatun, S., Mishra, S.K., Shrivastav, T.G. & Chaube, S.K. 2011. Melatonin protects against clomiphene citrate-induced generation of hydrogen peroxide and morphological apoptotic changes in rat eggs. European Journal of Pharmacology 667:419-424.
558
Konturek, P.C., Kania, J., Gesner, U., Konturek, S.J., Hahn, E.G. & Konturek, J.W. 2004. Effect of vitamin c-releasing acetylsalicylic acid on gastric mucosal damage before and after helicobacter pylori eradication therapy. European Journal of Pharmacology 506:169-177.
559
Searing, D.A., Zhang, Y., Murphy, J.R., Hauk, P.J., Goleva, E. & Leung, D.Y.M. 2010. Decreased serum vitamin d levels in children with asthma are associated with increased corticosteroid use. Journal of Allergy & Clinical Immunology 125(5):995-1000.
560
Boullata, JI. & Armenti, VT. 2004. Handbook of drug-nutrient interactions. Totowa:Humana.
561
Skversky, A.L., Kumar, J., Abramowitz, M.K., Kaskel, F.J. & Melamed, M.L. 2011. Association of glucocorticoid use and low 25-hydroxyvitamin d levels: results from the national health and nutrition examination survey (nhanes): 2001-2006. Journal of Clinical Endocrinology & Metabolism 96(12):3838-3845.
562
Prey, S. & Paul. C. 2009. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review. British Journal of Dermatology 160:622-628.
563
Lee, C.G., Boyko, E.J., Barrett-Connor, E., Miljkovic, I., Hoffman, A.R., Everson-Rose, S.A., Lewis, C.E., Cawthon, P.M., Strotmeyer, E.S. & Orwoll, E.S. 2011. Insulin sensitizers may attenuate lean mass loss in older men with diabetes. Diabetes Care 34:2381-2386.
564
Dakhale, G.N., Chaudhari, H.V. & Shrivastava, M. 2011. Supplementation of vitamin c reduces blood glucose and improves glycosylated hemoglobin in type 2 diabetes mellitus: a randomized, double-blind study. Advances in Pharmacological Sciences 2011; article ID 195271.
565
Culver, AL., Ockene, IS., Balasubramanian, R., Olendzki, BC., Sepavich, DM., Wactawski-Wende, J., Manson, JE., Qiao, Y., Liu, S., Merriam, PA., Rahilly-Tierny, C., Thomas, F., Berger, JS., Ockene, JK., Curb, JD. & Ma, Y. 2012. Statin use and risk of diabetes mellitus in postmenopausal women in the women's health initiative. Archives of Internal Medicine 172(2):144-152.
566
Preiss, D., Seshasai, S.R.K., Welsh, P., Murphy, S.A., Ho, J.E., Waters, D.D., deMicco, D.A., Barter, P., Cannon, C.P., Sabatine, M.S., Braunwald, E., Kastelein, J.J.P., de Lemos, J.A., Blazing, M.A., Pedersen, T.R., Tikkanen, M.J., Sattar, N. & Ray, K.K. 2011. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy a meta-analysis. JAMA 305(24):2556-2564.
567
Jacobson, T.A. 2004. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadminstered with cytochrome P450 inhibitors. The American Journal of Cardiology 94:1140-1146.
568
Bell, DSH. 2010. Resolution of statin-induced myalgias by correcting vitamin d deficiency. Southern Medical Journal 103(7):690-692.
569
Cuerda, C., Merchan-Naranjo, J., Velasco, C., Gutierrez, A., Leiva, M., de Castro, MJ., Parellada, M., Giraldez, M., Breton, I., Camblor, M., Garcia-Peris, P., Dulin, E., Sanz, I., Desco, M. & Arango, C. 2011. Influence of resting energy expenditure on weight gain in adolescents taking second-generation antipsychotics. Clinical Nutrition 30:616-623.
570
Aggarwal, A., Rastogi, N., Mittal, H., Chillar, N. & Patil, R. 2011. Thyroid hormone levels in children receiving carbamazepine or valproate. Pediatric Neurology 45:159-162.
571
Furlanetto, T.W. & Faulhaber, A.M. 2011. Hypomagnesemia and proton pump inhibitors below the tip of the iceberg. Archives of Internal Medicine 171(15):1391-1392.
572
Kuipers, M.T., Thang, H.D. & Arntzenius, A.B. 2009. Hypomagnesaemia due to use of proton pump inhibitors - a review. The Journal of Medicine 67(5):169-172.
573
Broeren, MAC., Geerdink, EAM., Vader, HL. & van den Wall Bake. AWL. 2009. Hypomagnesemia induced by several proton-pump inhibitors. Annals of Internal Medicine 151(10):755-756.
574
Mackay, J.D. & Bladon, P.T. 2010. Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series. Quality Journal of Medicine 103:387-395.
575
Wu, T-Y., Shen, C., Yin, J., Yu, J-P. & Meng, Q. 2006. Azathioprine hepatotoxicity and the protective effect of liquorice and glycyrrhizic acid. Phytotherapy Research 20:640-645.
576
Swannick, G., Hoa, V., Bidgood, M., Cheng, S., Death, R., dela Pena, A., FitzGerald, V., Georges, J., Gunewardhane, N., Harvey, A. Keen, S. 2012. june 2012 mims annual . St Leonards:UBM Medica Australia.
577
Farrell, C.P., Morgan, M., Rudolph, D.S., Hwang, A., Albert, N.E., Valenzano, M.C., Wang, X., Mercogliano, G. & Mullin, J.M. 2011. Proton pump inhibitors interfere with zinc absorption and zinc body stores. Gastroenterology Research 4(6):243-251.
578
FDA Drug Safety Communication. 2011. Low magnesium levels can be associated with long-term use of proton pump inhibitor drugs. 3/2/2011.
579
Bavishi, C. & DuPont, HL. 2011. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Alimentary Pharmacology & Therapeutics 34(11):1269-1281.
580
Diesner, S.C., Untersmayr, E., Pietschmann, P. & Jensen-Jarolim, E. 2011. Food allery: only a pediatric disease? Gerontology 57:28-32.
581
Cundy, T. & Dissanayake, A. 2008. Severe hypomagnesaemia in long-term users of proton-pump inhibitors. Clinical Endocrinology 69:338-341.
582
Hansen, K.E., Jones, A.N., Lindstrom, M.J., Davis, L.A., Ziegler, T.E., Penniston, K.L., Alvig, A.L. & Shafer, M.M. 2010. Do proton pump inhibitors decrease calcium absorption? Journal of Bone and Mineral Research 25(12):2786-2795.
583
Ratuapli, S.K., Ellington, T.G., O'Neill, M., Umar, S.B., Harris, L.A., Foxx-Orenstein, A.E., Burdick, G.E., DiBaise, J.K., Lacy, B.E. & Crowell, M.D. 2012. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth. American Journal of Gastroenterology 107(5):730-735.
584
Matsuyama, J., Tsuji, K., Doyama, H., Kim, F., Takeda, Y., Kito. Y., Ito, R., Nakanishi, H., Hayashi, T., Waseda, Y., Tsuji, S., Takemura, K., Yamada, S., Okada, T. & Kanaya, H. 2012. Hypomagnesemia associated with a proton pump inhibitor. Internal Medicine 51:2231-2234.
585
Medicines & Healthcare Products Regulatory Agency. 2012. Proton pump inhibitors in long term use: reports of hypomagnesaemia. Drug Safety Update 5(9):A1.
586
Hess, M.W., Hoenderop, J.G.J., Bindels, R.J.M. & Drenth, J.P.H. 2012. Systematic review: hypomagnesaemia induced by proton pump inhibition. Alimentary Pharmacology & Therapeutics 36(5):405-413.
587
Gude, D. 2011. Epilepsy, anti-epileptic drugs and bone health in children. Journal of Pediatric Neurosciences 6(1):93
588
Cansu, A., Yesilkaya, E., Serdaroglu, A., Hirfanoglu, T., Camurdan, O., Gulbahar, O., Gucuyener, K. & Cinaz, P. 2008. Evaluation of bone turnover in epileptic children using oxcarbazepine. Pediatric Neurology 39(4):266-271.
589
Pack, A. 2008. Bone health in people with epilepsy: is it impaired and what are the risk factors? Seizure 17:181-186.
590
Kim, S., Lee, J., Choi, K., Chung, H. & Lee, H. 2007. A 6-month study of bone mineral density with antiepileptic drug monotherapy. Epilepsy & Behaviour 10:291-295.
591
Cansu, A., Serdaroglu, A., Biberoglu, G., Tumer, L., Hirfanoglu, T., Ezgu, F. & Hasanoglu, A. 2011. Analysis of acylcarnitine levels by tandem mass spectrometry in epileptic children receiving valproate and oxcarbazepine. Epileptic Disorders 13(4):394-400.
592
Anil, M., Helvaci, H., Ozbal, E., Kalenderer, O., Anil, A. & Dilek, M., 2009. Serum and muscle carnitine levels in epileptic children receiving sodium valproate. Journal of Child Neurology 24:80-86.
593
Hamed, S. & Abdella, M. 2009. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status. Epilesy Research 86:32-41.
594
Zelnik, N., Isler, N., Goez, H., Shiffer, M., David, M. & Shahar, E. 2008. Vigabatrin, lamotrigine, topiramate and serum carnitine levels. Pediatric Neurology 39:18-21.
595
Coppola, G., Epifanio, G., Auricchio, G., Federico, R., Resicato, G. & Pascotto, A. 2006. Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet. Brain & Development 28:358-365.
596
Linnebank, M., Moskau, S., Semmler, A., Widman, G., Stoffel-Wagner, B., Weller, M. & Elger, C. 2011. Antiepileptic drugs interact with folate and vitamin B12 serum levels. Annals of Neurology 69(2):352-359.
597
Belcastro, V., Striano, P., Gorgone, G., Costa, C., Ciampa, C., Caccamo, D., Pisani, L., Oteri, G., Marciani, M., Aguglia, U., Striano. S., Lentile, R., Calabresi, P. & Pisani, F. 2010. Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. Epilepsia 51(2):274-279.
598
Kampman, M. 2007. Folate status in women of childbearing age with epilepsy. Epilepsy Research 75:52-56.
599
Nettekoven, S., Strohle, A., Trunz, B., Wolters, M., Hoffmann, S., Horn, R., Steinert, M., Brabant, G., Lichtinghagen, R., Welkoborsky, H., Tuxhorn, I. & Hahn, H. 2008. Effects of antiepileptic drug therapy on vitamin d status and biochemical markers of bone turnover in children with epilepsy. European Journal of Pediatics 167:1369-1377.
600
Safar, M.M., Abdullah, D.M., Arafa, N.M. & Abdel-Aziz, M.T. 2010. Magnesium supplementation enhances the anticonvulsant potential of valproate in pentylenetetrazol-treated rats. Brain Research 1334:58-64.
601
Prodam, F., Bellone, S., Casara, G., de Rienzo, F., Grassino, E.C., Bonsignori, I., Demarchi, I., Rapa, A., Radetti, G. & Bona, G. 2010. Ghrelin levels are reduced in prepubertal epileptic children under treatment with carbamazepine or valproic acid. Epilepsia 51(2):312-315.
602
Davison, A.S., Milan, A.M. & Roberts, N.B. 2011. The consequences of valproate overdose. Clinical Chemistry 57(9):1233-1238.
604
Ma, T., Chang, M., Tien, L., Liou, Y. & Jong, G. 2012. The long-term effect of statins on the risk of new-onset diabetes mellitus in elderly taiwanese patients with hypertension and dyslipidaemia. Drugs & Aging 29(1):45-51.
605
Sattar, N., Preiss, D., Murray, H.M., Welsh, P., Buckley, B.M., de Craen, A.J.M., Seshasai, S.R.K., McMurray, J.J., Freeman, D.J., Jukema, J.W., Macfarlane, P.W., Packand, C.J., Stott, D.J., Westendorp, R.G., Shepherd, J., Davis, B.R., Pressel, S.L., Marchioli, R., Marfisi, R.M., Maggioni, A.P., Tavazzi, L., Tognoni, G., Kjekshus, J., Pedersen, T.R., Cook, T.J., Gotto, A.M., Clearfield, MB., Downs, J.R., Nakamura, H., Ohashi, Y., Mizuno, K., Ray, K.K., & Ford, I. 2010. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 275:735-742.
606
Meyer, B.J., Hammervold, T., Rustan, A.C. & Howe, P.R.C. 2007. Dose-dependent effects of docosahexaenoic acid supplementation on blood lipids in statin-treated hyperlipidaemic subjects. Lipids 42(2):109-115.
607
Vishwanathan, R., Goodrow-Kotyla, E.F., Wooten, B.R., Wilson, T.A. & Nicolosi, R.J. 2009. Consumption of 2 and 4 egg yolks/d for 5 wk increases macular pigment concentrations in older adults with low macular pigment taking cholesterol-lowering statins. American Journal of Clinical Nutrition 90:1272-1279.
608
Brookes, L. & Ansell, JE. 2010. Warfarin and cranberry juice: time to lose the warning. Medscape. www.medscape.com/viewarticle727471.
609
Buckley, MS., Goff, AD. & Knapp, WE. 2004. Fish oil interaction with warfarin. The Annals of Pharmacotherapy 38:50-53.
610
Dickerson, R.N., Garmon, W.M., Kuhl, D.A., Minard, G. & Brown, R.O. 2008. Vitamin k-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition. Pharmacotherapy 28(3):308-313.
611
Lipscombe, L.L., Fischer, H.D., Yun, L., Gruneir, A., Austin, P., Paszat, L., Anderson, G.M. & Rochon. P.A. 2012. Association between tamoxifen treatment and diabetes. Cancer 118(10):2615-2622.
612
Gillessen, S., Graf, L., Korte, W. & Cerny, T. 2007. Macrocytosis and cobalamin deficieny in patients treated with sunitinib. New England Journal of Medicine 356(22):2330-2331.
613
Billemont, B., Izzedine, H. & Rixe, O. 2007. Macrocytosis due to treatment with sunitinib. New England Journal of Medicine 357(13):1351-1352.
614
Rabie, M.A., Zaki, H.F., Bahgat, A.K. & Abd El-Latif, H.A. 2012. Angiotensin antagonists and renal ischemia/reperfusion: possible modulation by l-carnitine. Bulletin of Faculty of Pharmacy, Cairo University 50:7-16.
615
Vegter, S., Perna, A., Postma, M.J., Navis, G., Remuzzi, G. & Ruggenenti, P. 2012. Sodium intake, ace inhibition, and progression to esrd. Journal of the American Society of Nephrology 23(1):165-173.
616
Guo, W., Wong, S., Pudney, J., Jasuja, R., Hua, N., Jiang, L., Miller, A., Hruz, P.W., Hamilton, J.A. & Bhasin, S. 2009. Acipimox, an inhibitor of lipolysis, attenuates atherogenesis in ldlr null mice treated with hiv protease inhibitor ritonavir. Arteriosclerosis, Thrombosis & Vascular Biology 29(12):2028-2032.
617
Freedman, N.D., Curto, T.M., Lindsay, K.L., Wright, E.C., Sinha, R. & Everhart, J.E. 2011. Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis c. Gastroenterology 140(7):1961-1969.
618
Yanagawa, N., Shih, R.N.G., Oak, K.J. & Said, H.M. 2000. Riboflavin transport by isolated perfused rabbit renal proximal tubules. American Journal of Physiology Cell Physiology 279:C1782-C1786.
619
Bitetto, D., Fabris, C., Fornasiere, E., Pipan, C., Fumolo, E., Cussigh, A., Bignulin, S., Cmet, S., Fontanini, E., Falleti, E., Martinella, R., Pirisi, M. & Toniutto, P. 2011. Vitamin d supplementation improves response to antiviral treatment for recurrent hepatitis c. Transplant International 24(1):43-50.
620
Valcour, V., Yeh, T-M., Bartt, R., Clifford, D., Gerschenson, M., Evans, S.R., Cohen, B.A., Ebenezer, G.J., Hauer, P., Millar, L., Gould, M., Tran, P., Shikuma, C., Souza, S., McArthur, J.C. and the AIDS Clinical Trials Group (ACTG) 5157 protocol team. 2009. Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in hiv infection. HIV Medicine 10:103-110.
621
Herzmann, C., Johnson, M.A. & Youle, M. 2005. Long-term effect of acetyl-l-carnitine for antiretroviral toxic neuropathy. HIV Clinical Trials 6(6):344-350.
622
Takasu, N., Takara, M. & Komiya, I. 2005. Rifampin-induced hypothyroidism in patients with hashimoto's thyroiditis. New England Journal of Medicine 352(5):518-519.
623
Gillman, P.K. 2011. Monoamine oxidase inhibitors (maoi), dietary restrictions, tyramine, cheese and drug interactions. V 2.2.1. http://psychotropical.com
624
Williams, S.G., Alinejad, N.A., Williams, J.A. & Cruess, D.F. 2010. Statistically significant increase in weight caused by low-dose quetiapine. Pharmacotherapy 30(10):1011-1015.
625
Deng, C., Weston-Green, K. & Huang, X. 2010. The role of histaminergic h1 and h3 receptors in food intake: a mechanism for atypical antipsychotic-induced weight gain? Progress in Neuro-Psychopharmacology & Biological Psychiatry 34:1-4.
626
Bird, ST., Pepe, SR., Etminan, M., Liu, X., Brophy, JM. & Delaney, JAC. 2011. The association between drospirenone and hyperkalaemia. BMC Clinical Pharmacology 11(23):1-6.
627
Yahyavi-Firouz-Abadi, N., Tahsili-Fahadan, P., Riazi, K., Ghahremani, M.H. & Dehpour, A.R. 2007. Melatonin enhances the anticonvulsant and proconvulsant effects of morphine in mice: role for nitric oxide signalling pathway. Epilepsy Research 75:138-144.
628
Tsuruoka, S., Wakaumi, M., Araki, N., Ioka, T., Sugimoto, K. & Fujimura, A. 2005. Comparative study of taste disturbance by losartan and perindopril in healthy volunteers. Journal of Clinical Pharmacology 45:1319-1323.
629
Petta, S., Camma, C., Scazzone, C., Tripodo, C., di Marco, V., Bono, A., Cabibi, D., Licata, G., Porcasi, R., Marchesini, G. & Craxi, A. 2010. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis c. Hepatology 51:1158-1167.
630
Busti, AJ., Herrington, JD., Lehew, DS., Daves, BJ. & McKeever, GC. 2009. How can the oral antiarrhythmic medication, amiodarone (cordarone) cause hypothyroidism and is it relevant? PW Pharmacotherapy Newsletter 1(2):1-4.
631
Loh, K-C. 2000. Amiodarone-induced thyroid disorders: a clinical review. Postgraduate Medicine Journal 76:133-140.
632
Gal-Tanamy, M., Bachmetov, L., Ravid, A., Koren, R., Erman, A., Tur-Kaspa, R. & Zemel, R. 2011. Vitamin d: an innate antiviral agent suppressing hepatitis c virus in human hepatocytes. Hepatology 54:1570-1579 There is something about this reference that the program does not recognise and therefore it shows as a 0; see also reference 618
633
Swannick, G., Hoa, V., Au, L., Bidgood, M., Cheng, S., Death, R., dela Pena, A., FitzGerald, V., Georges, J., Gunewardhane, N., Harvey, A. Keen, S. 2013. june 2013 mims annual . St Leonards:MIMS Australia.
634
Swannick, G., Hoa, V., Au, L., Bidgood, M., Cheng, S., Death, R., dela Pena, A., FitzGerald, V., Georges, J., Gunewardhane, N., Harvey, A. Keen, S. 2013. MIMS quarterly November/December Issue 4. St Leonards:MIMS Australia.
635
Clyman, R., Wickremasinghe, A., Jhaveri, N., Hassinger, D., Attridge, J., Sanocka, U., Polin, R., Gillam-Krakauer, M., Reese, J., Mammel, M., Couser, R., Mulrooney, N., Yanowitz, T., Derrick, M., Jegatheesan, P., Walsh, M., Fujii, A., Porta, N., Carey, W. & Swanson, J. 2013. Enteral feeding during indomethacin and ibuprofen treatment of a patent ductus arteriosus. The Journal of Pediatrics 263(2):406-411.
636
Klang, M., McLymont, V. & Ng, N. 2013. Osmolality, pH, and compatibility of selected oral liquid medications with an enteral nutrition product. Journal of Parenteral & Enteral Nutrition 37(5):689-694.
637
Love, A.L. & Billett, H.H. 2008. Obesity, bariatric surgery, and iron deficiency: true, true, true, and related. American Journal of Hematology 83:403-409.
638
Bankhead, R., Boullata, J., Brantley, S., Corkins, M., Guenter, P., Krenitsky, J., Lyman, B., Metheny, N., Mueller, C., Robbins, S., Wessel, J. & ASPEN Board of Directors 2009. 2009. A.S.P.E.N. Enteral Nutrition Practice Recommendations. Journal of Parenteral & Enteral Nutrition 33(2):122-167.
639
Warsch, S. & Byrnes, J. 2013. Emerging causes of iron deficiency anemia refractory to oral iron supplementation. World Journal of Gastrointestinal Pharmacology & Therapeutics 4(3):49-53.
640
Barbesino, G. 2010. Drugs affecting thyroid function. Thyroid 20(7):763-770.
641
Emeksiz, HC., Serdaroglu, A., Biberoglu, G., Gulbahar, O., Arhan, E., Cansu, A., Arga, M. & Hasanoglu, A. 2013. Assessment of atherosclerosis risk due to the homocysteine-asymmetric dimethylarginine-nitric oxide cascade in children taking antiepileptic drugs. Seizure 22:124-127
642
Wen, D., Cornelius, RJ. & Sansom, SC. 2014. Interacting influence of diuretics and diet on BK channel-regulated K homeostasis. Current Opinion in Pharmacology 15:28-32.
643
Yong, TY., Huang, JE., Lau, SY. & Li, JY. 2011. Severe hyponatremia and other electrolyte disturbances associated with indapamide. Current Drug Safety 6(3):134-137.
644
Fotino, A.D., Thompson-Paul, A.M. & Bazzano, L.A. 2013. Effect of coenzyme Q10 supplementation on heart failure: a meta-analysis. American Journal of Clinical Nutrition 97:268-275.
645
Bojko, B., Sulkowska, A., Maciazek-Jurczyk, M., Rownicka, J., Pentak, D. & Sulkowski, WW. 2010. Alterations of furosemide binding to serum albumin induced by increased level of fatty acid. Journal of Pharmaceutical & Biomedical Analysis 51:273-277.
646
Komperda, K.E. 2009. Potential interaction between pomegranate juice and warfarin. Pharmacotherapy 29(8):1002-1006.
647
Jarvis, S., Li, C & Bogle, R.G. 2010. Possible interaction between pomegranate juice and warfarin. Emergency Medicine Journal 27(1):74-75
648
Zikria, J., Goldman, R. & Ansell, J. 2010. Cranberry juice and warfarin: when bad publicity trumps science. The American Journal of Medicine 123(5):384-392.
649
Nutescu, E., Chuatrisorn, I. & Hellenbart, E. 2011. Drug and dietary interactions of warfarin and novel oral anticoagulants: an update. Journal of Thrombosis and Thrombolysis 31:326-343.
650
Negri, A.L. & del Valle, E.E. 2011. Hypomagnesaemia/hypokalaemia associated with the use of esomeprazole. Current Drug Safety 6(3):204-206.
651
Hoorn, E.J., van der Hoek, J., de Man R.A., Kuipers, E.J., Bolerk, C. & Zietse, R. 2010. A case series of proton pump inhibitor-induced hypomagnesemia. American Journal of Kidney Diseases 56(1):112-116.
652
Sankar, D., Ali, A., Sambandam, G. & Rao, R. 2011. Sesame oil exhibits synergistic effect with anti-diabetic medication in patients with type 2 diabetes mellitus. Clinical Nutrition 30:351-358.
653
Fijlstra, M., Tissing, W.J.E., Stellaard, F., Verkade, H.J. & Rings, E.H.H.M. 2013. Reduced absorption of long-chain fatty acids during methotrexate-induced gastrointestinal mucositis in the rat. Clinical Nutrition 32:452-459.
654
Mahajan, R. & Gupta, K. 2010. Revisiting metformin: annual vitamin b12 supplementation may become mandatory with long-term metformin use. Journal of Young Pharmacists 2(4):428-429.
655
Kibirige, D. & Mwebaze, R. 2013. Vitamin b12 deficiency among patients with diabetes mellitus: is routine screening and supplementation justified? Journal of Diabetes & Metabolic Disorders 12:17-22.
656
McColl, K.E.L. 2009. Effect of proton pump inhibitors on vitamins and iron. The American Journal of Gastroenterology 104 (Supp 2):S5-S9.
657
Danziger, J., William, J.H., Scott, D.J., Lee, J., Lehman, L., Mark, R.G., Howell, M.D., Celi, L.A. & Mukamal, K.J. 2013. Proton-pump inhibitor use is associated with low serum magnesium concentrations. Kidney International 83:692-699.
658
Lebwohl, B., Spechler, S.J., Wang, T.C., Green, P.H.R. & Ludvigsson, J.F. 2014. Use of proton pump inhibitors and subsequent risk of celiac disease. Digestive & Liver Disease 46(1):36-40.
659
Lam, J.R., Schneider, J.L., Zhao, W. & Corley, D.A. 2013. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin b12 deficiency. JAMA 310(22):2435-2442.
660
Kanazi, G.E., El-Khatib, M.F., Yazbeck-Karam, V.G., Hanna, J.E., Masri, B. & Aouad, M.T. 2012. Effect of vitamin c on morphine use after laparoscopic cholecystectomy: a randomized controlled trial. Canadian Journal of Anesthesia 59:538-543.
661
Sica, D.A. 2007. Loop diuretic therapy, thiamine balance, and heart failure. Congestive Heart Failure 13(4):244-247.
662
DiNicolantonio, J.J., Lavie, C.J., Niazi, A.K., O'Keefe, J.H. & Hu, T. 2013. Effects of thiamine on cardiac function in patients with systolic heart failure: systematic review and metaanalysis of randomized, double-blind, placebo-controlled trials. The Ochsner Journal 13(4):495-499.
663
DiNicolantonio, J.J., Niazi, A.K., Lavie, C.J., O'Keefe, J.H. & Ventura, H.O. 2013. Thiamine supplementation for the treatment of heart failure: a review of the literature. Congestive Heart Failure 19(4):214-222.
664
Lameris, A.L., Monnens, L.A., Bindels, R.J. & Hoenderop, G.J. 2012. Drug-induced alterations in mg2+ homeostasis. Clinical Science 123:1-14.
665
Castro-Gago, M., Perez-Guy, L., Gomez-Lado, C., Castineiras-Ramos, DE., Otero-Martinez, S. & Rodriguez-Segade, S. 2011. The influence of valproic acid and carbamazepine treatment on serum biotin and zinc levels and on biotinidase activity. Journal of Child Neurology 26(12):1522-1524.
666
Swannick, G., Hoa, V., Au, L., Bidgood, M., Cheng, S., Death, R., dela Pena, A., FitzGerald, V., Georges, J., Gu, P., Gunewardhane, N., Harvey, A., Keen, S. & Prasad, R. 2014. june 2014 mims annual . St Leonards:MIMS Australia.
669
ViiV Healthcare ULC. 20014. Canada tivicay product monograph. www.viivhealthcare/com/media/76391/Tivicay_PM-2014-03-11.pdf. Accessed 2015-01-03.
670
Viiv Healthcare 2014. European Prescribing Information. www.viivhealthcare.com/media/74706/EU_Tivicay.pdf. Accessed 2015-01-03.
671
Viiv Healthcare. 2014. US tivicay prescribing information. www.viivhealthcare.com/media/58599/us_tivicay.pdf. Accessed 2015-01-03.
672
Leonard, C.E., Razzaghi, H., Freeman, C.P., Roy, J.A., Newcomb, C.W. & Hennessy, S. 2014. Empiric potassium supplementation and increased survival in users of loop diiuretics. PLoS ONE 9(7):e102279.
673
Chen, L., Shu, Y., Liang, X., Chen, EC., Yee, SW., Zur, AA., Li, S., Xu, L., Keshari, KR., Lin, MJ., Chien, H., Zhang, Y., Morrissey, KM., Liu, J. & Giacomini, KM. 2014. Oct1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin. Proceedings of the National Academy of Sciences 111(27) :9983-9988.
674
Hu, C., Lancaster, C.S., Zuo, Z., Hu, S., Chen, Z., Rubnitz, J.E., Baker, S.D. & Sparreboom, A. 2012. Inhibition of octn2-mediated transport of carnitine by etoposide. Molecular Cancer Therapeutics 11(4):921-929.
675
Egom, EEA., Chirico, D. & Clark, AL. 2011. A review of thiazide-induced hyponatraemia. Clinical Medicine 11(5):448-451.
676
Leung, A.A., Wright, A., Pazo, V., Karson, A. & Bates, D.W. 2011. Risk of thiazide-induced hyponatremia in patients with hypertension. The American Journal of Medicine 124:1064-1072.
677
Perez, A., Jansen-Chaparro, S., Saigi, I., Bernal-Lopez, R., Minambres, I. & Gomez-Huelgas, R. 2013. Glucocorticoid-induced hyperglycemia. Journal of Diabetes 6:9-20.
678
Marcantonio, E.E., Ballard, J., Gibson, C.R., Kassahun, K., Palamanda, J., Tang, C., Evers, R., Liu, C., Zajic, S., Mahon, C., Mostoller, K., Hreniuk, D., Mehta, A., Morris, D., Wagner, J.A. & Stoch, S.A. 2014. Prednisone has no effect on the pharmacokinetics of cyp3a4 metabolized drugs - midazolam and odanacatib. The Journal of Clinical Pharmacology 54(11):1280-1289.
679
DiFabio, J.M., Gori, T., Thomas, G.R., Jedrzkiewica, S.J. & Parker, J.D. 2010. Daily low-dose folic acid supplementation does not prevent nitroglycerin-induced nitric oxide synthase dysfunction and tolerance: a human in vivo study. Candian Journal of Cardiology 26(9):461-465.
680
Gilbar, P.J., Richmond, J., Wood, J. & Sullivan, A. 2012. Syndrome of inappropriate antidiuretic hormone secretion induced by a single dose of oral cyclophosphamide. The Annals of Pharmacotherapy 46:e23.
681
Ozcelik, A.A., Serdaroglu, A., Bideci, A., Arhan, E., Soysal, S., Demir, E. & Gucuyener, K. 2014. The effect of topiramate on body weight and ghrelin, leptin, and neuropeptide-y levels of prepubertal children with epilepsy. Pediatric Neurology 51:220-224.
682
Kanemura, H., Sano, F., Maeda, Y., Sugita, K. & Aihara, M. 2012. Valproate sodium enhances body weight gain in patients with childhood epilepsy: a pathogenic mechanisms and open-label clinical trial of behavior therapy. Seizure 21:496-500.
683
Yilmaz, U., Yilmaz, T.S., Akinci, G., Korkmaz, H.A. & Tekgul, H. 2014. The effect of antiepileptic drugs on thyroid function in children. Seizure 23:29-35.
684
Felker, D., Lynn, A., Wang, S. & Johnson, D.E. 2014. Evidence for a potential protective effect of carnitine-pantothenic acid co-treatment on valproic acid-induced hepatotoxicity. Expert Reviews in Clinical Pharmacology 7(2):211-218.
685
American Society of Health-System Pharmacists. 2013. Ibandronate. Medline Plus. US National Library of Medicine National Institutes of Health.
686
Sandoz. 2013. Product information Alendronate Sandoz. Sandoz Pty Ltd.
687
American Society of Health-System Pharmacists. 2013. Risedronate. Medline Plus. US National Library of Medicine National Institutes of Health.
688
Issa, M.M., Nejem, R.M. & Shanab, A.A. 2013. Effects of iron on the pharmacokinetics of paracetamol in saliva. Pakistan Journal of Biological Sciences 16(24):2050-2053.
689
van der Hoeven, N., Schene, A. & van den Born, B. 2014. Severe hypertension related to caffeinated coffee and tranylcypromine: a case report. Annals of Internal Medicine 160(9):657-658.
690
Bourne, C., Gouraud, A., Daveluy, A., Grandvuillemin, A., Auriche, P., Descotes, J., Vial, T. & The French Association of Regional Pharmacovigilance Centres. 2012. Tramadol and hypoglycaemia: comparison with other step 2 analgesic drugs. British Journal of Clinical Pharmacology 75(4):1063-1067.
691
Pierce, S.A., Chung, A.H. & Black, K.K. 2012. Evaluation of vitamin b12 monitoring in a veteran population on long-term, high-dose metformin therapy. The Annals of Pharmacotherapy 46:1470-1476.
692
Jin, M. & Han, H. 2010. Effect of piperine, a major component of black pepper, on the intestinal absorption of fexofenadine and its implication on food-drug interaction. Journal of Food Science 75(3):H93-H96.
693
Cederberg, H., Stancakova, A., Yaluri, N., Modi, S., Kuusisto, J. & Laakso, M. 2015. Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the metsim cohort. Diabetologia DOI 10.1007/s00125-015-3528-5.
694
Takeda, Y., Kubota, M., Sato, H., Nagai, A., Higashiyama, Y., Kin, H., Kawaguchi, C. & Tomiwa, K. 2015. Carnitine in severely disabled patients: relation to anthropometric, biochemical variables, and nutritional intake. Brain & Development 37:94-100.
695
Rohner, F., Zimmermann, M., Jooste, P., Pandav, C., Caldwell, K., Raghavan, R. & Raiten, D.J. 2014. Biomarkers of nutrition for development - iodine review. Journal of Nutrition 144:1322S-1342S.
696
Bobo, WV., Cooper, WO., Stein, CM., Olfson, M., Graham, D., Daugherty, J., Fuchs, DC. & Ray, WA. 2013. Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. JAMA Psychiatry 70(10):1067-1075.
697
Ravi, P.R., Vats, R., Thakur, R., Srivani, S. & Aditya, N. 2012. Effect of grapefruit juice and ritonavir on pharmacokinetics of lopinavir in wistar rats. Phytotherapy Research 26:1490-1495.
698
Bonnici, A., Ruiner, C., St-Laurent, L. & Hornstein, D. 2010. An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged icu stay. The Annals of Pharmacotherapy 44:1504-1507.
699
Davoren, P. 2014. Safe prescribing of metformin in diabetes. Australian Prescriber 37(1):2-5.
700
Hvas, A. & Nexo, B. 2006. Diagnosis and treatment of vitamin b12 deficiency:an update. Haematologica 91:1506-1512.
701
Dahan, A. & Amidon, GL. 2009. Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein. Pharmaceutical Research 26(4):883-892.
702
Deane, A.M., Wong, G.L., Horowitz, M., Zaknic, A,V., Summers, M.J., di Bartolomeo, A.E., Sim, J.A., Maddox, A.F., Bellon, M.S., Rayner, C.K., Chapman, M.J. & Fraser, R.J.L. 2012. Randomized double-blind crossover study to determine the effects of erythromycin on small intestinal nutrient absorption and transit in the critically ill. American Journal of Clinical Nutrition 95:1396-1402.
703
Branch, AD., Kang, M., Hollabaugh, K., Wyatt, CM., Chung, RT. & Glesby, MJ. 2013. In hiv/hepatitis c virus co-infected patients, higher 25-hydroxyvitamin d concentrations were not related to hepatitis c virus treatment responses but were associated with ritonavir use. American Journal of Clinical Nutrition 98:423-429.
704
Nimer, A. & Mouch, A. 2012. Vitamin D improves viral response in hepatitis c genotype 2-3 naïve patients. World Journal of Gastroenterology 18(8):800-805.
705
Abu-Mouch, S., Fireman, Z., Jarchovsky, J., Zeina, A. & Nimer, A. 2011. Vitamin d supplementation improves sustained virologic response in chronic hepatitis c (genotype 1)-naïve patients. World Journal of Gastroenterology 17(47):5184-5190.
706
Canale, D., de Braganca, A., Goncalves, J., Shimizu, M., Sanches, T., Andrade, L, Volpini, R. & Seguro, A. 2014. Vitamin d deficiency aggravates nephrotoxicity, hypertension and dyslipidemia caused by tenofovir: role of oxidative stress and renin-angiotensin system. PLoS ONE 9(7):e103055.
707
Slagman, M.C.J., Waanders, F., Hemmelder, M.H., Woittiez, A., Janssen, W.M.T., Heerspink, H.J.L., Navis, G. & Laverman, G.D. 2011. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial. British Medical Journal 343:d4366.
708
Vogt, L., Waanders, F., Boomsma, F., de Zeeuw, D. & Navis, G. 2008. Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. Journal of the American Society of Nephrology 19(5):999-1007.
709
Alshafei, MM., Kassem, SS. & Abdel kader, MM. 2013. Effect of long term treatment with antiepileptic drugs on oxidant status, zinc and magnesium in epileptic patients. World of Applied Sciences Journal 28(3):316-323.
710
Waring, W.S. & Nixon, A.C. 2009. Acute liver impairment after sodium valproate overdose. British Medical Journal Case Reports bcr06.2008.0057; online doi: 10.1136/bcr.06.2008.0057
711
Abd El Dayem, SM., Saleh, ON., Emara, NA., Kandil, ME., Shatla, RH. & Elgammal, S. 2014. Evaluation of homocysteine, folic acid and vitamin b12 levels among egyptian children with idiopathic epilepsy. Macedonian Journal of Medical Sciences 7(1):109-113.
712
Kumar, V., Aggarwal, A., Sharma, S., Chillar, N., Mittal, H. & Faridi, M.M.A. 2013. Effect of carbamazepine therapy on homocysteine, vitamin b12 and folic acid levels in children with epilepsy. Indian Pediatrics 50:469-472.
713
Gorjipour, F., Asadi, Y., Osguei, N.K., Effatkhah, M. & Samadikuchaksaraei, A. 2013. Serum level of homocysteine, folate and vitamin-b12 in epileptic patients under carbamazepine and sodium valproate treatment: a systematic review and meta-analysis. Iranian Red Crescent Medical Journal 15(3):249-253.
714
Eldeen, O.N., Abd Eldayem, S.M., Shatla, R.H., Omara. N.A. & Elgammal, S.S. 2012. Homocysteine, folic acid and vitamin b12 levels in serum of epileptic children. The Egyptian Journal of Medical Human Genetics 13:275-280.
715
Chuang, Y., Chuang, H., Lin, T., Chang, C., Lu, C., Chang, W., Chen, S., Tan, T., Huang, C. & Chan, S. 2012. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. Epilepsia 53(1):120-128.
716
Mintzer, S, Skidmore, C.T. & Sperling, M.R. 2012. B-vitamin deficiency in patients treated with antiepileptic drugs. Epilepsy Behaviour 24(3):341-344.
717
Siniscalchi, A., de Sarro, G., Loizzo, S. & Gallelli, L. 2012. High plasma homocysteine and low serum folate levels induced by antiepileptic drugs in down syndrome. Journal of Developmental Disabilities 18(2):70-76.
718
Toh, J.W.T., Ong, E. & Wilson, R. 2015. Case Report Hypomagnesaemia associated with long-term use of proton pump inhibitors. Gastroenterology Report (Oxf) 3(3):243-253.
719
Paknahad, Z., Chitsaz, A., Zadeh, A.H. & Sheklabadi, E. 2012. Effects of common anti-epileptic drugs on the serum levels of homocysteine and folic acid. International Journal of Preventive Medicine 3(Suppl):S186-S190.
720
Zariwala, MG., Somavarapu, S., Farnaud, S. & Renshaw, D. 2013. Comparison study of oral iron preparations using a human intestinal model. Scientia Pharmaceutica 81:1123-1139.
721
caltrate.com.au. Caltrate Bone Health. www.caltrate.com.au/caltrate-bone-health Accessed 11/01/2016.
722
Hoa, V., Au, L., Bidgood, M., Brewster, J., Cheng, S., Death, R., dela Pena, A., FitzGerald, V., Georges, J., Gu, P., Gunewardhane, N., Harvey, A., Keen, S., Montagnino, S. & Naziri, E. 2015. june 2015 mims annual . St Leonards:MIMS Australia.
723
ebs.tga.gov.au. 2016. Australian Register of Therapeutic Goods. www.ebs.tga.gov.au. Accessed January 2016.
724
2016. https:medicines.org.au. Accessed 2016.
725
2016. NPS. www.nps.org.au. Accessed 17th March 2016.
726
Personal Communication. 2016. Elemental nutrient content. Phone advice.
728
Khanna, N.C. & Sharma, S.K.1983. Megadoses of vitamin c prevent the development of tolerance and physical dependence on morphine in mice. Life Sciences. 33(1):401-404
729
Naharci, I.M., Karadurmus, N. & Doruk, H. 2011. Rivastigmine associated hyponatraemia in an older patient with alzheimer's disease. Case Report. Journal of the American Geriatric Society 59:1351-1352
731
Meng, X., Li, Y., Li, S., Zhou, Y., Gan, R-Y., Xu, D-P. & Li, H-B. 2017. Dietary sources and bioactivities of melatonin. uNutrients 9(4):pii E367
732
Bozdag-Pehlivan, S., Subasi, B., Vural, I., Unlo, N. and Capan, Y. 2011. Evaluation of drug-excipient interaction in the fomulation of celecoxib tablets. Acta Polomiac Pharmaceutica - Drug Research 68(3):423-433.
733
Ohki, M. and Tayama, N. 2012. Dyspha733gia due to isoniazid therapy for tuberculosis in a patient with lewy body dementia. Auris Nasus Larynx 40(3):327-329.
734
Ganesan, S., Williams, D., Maslen, C.L. and Cherala, G. 2012. Clopidogrel variability: role of plasma protein binding alterations. British Journal of Clinical Pharmacology 75(6):1468-1477.
735
Darwish, M., Kirby, M., Robertson, P. and Hellriegel, E.T. 2008. Interaction profile of armodafinil with medications metabolized by cytochrome p450 enzymes 1a2, 3a4 and 2c19 in healthy subjects. Clinical Pharmacokinetics 47(1):61-74.
736
Clooney, AG., Bernstein, CN., Leslie, WD., Bagianos, K., Sargent, M., Laserna-Mendieta, EJ., Claesson, MJ. & Targownik, LE. 2016. A comparison of the gut microbiome between long-term users of non-users of proton pump inhibitors. Alimentary Pharmacology & Therapeutics 43:974-984.
737
Jung, S.B., Nagaraja, V., Kapur, A. & Eslick, G.D. 2015. Association between vitamin B12 deficiency and long-term use of acid-lowering agents: a systemic review and meta-analysis. Internal Medicine Journal 45(4):409-416.
738
Smith, A.D. 2016. Hippocampus as a mediator of the role of vitamin B-12 in memory. American Journal of Clinical Nutrition 103:959-960.
739
Kobe, T., Witte, A.V., Schnelle, A., Grittner, U., Tesky, V.A., Pantel, J., Schuchardt, J.P., Hahn, A., Bohlken, J., Fujescu, D. & Floel, A. 2016. Vitamin B-12 concentration, memory performance, and hippocampal structure in patients with mild cognitive impairment. American Journal of Clinical Nutrition 103:1045-1054.
740
Fotaki, N. & Klein, S. 2013. Mechanistic understanding of the effect of PPIs and acidic carbonated beverages on the oral absorption of itraconazole based on absorption modelling with appropriate in vitro data. Molecular Pharmaceutics 10:4016-4023.
741
Mansi, I., Frei, C.R., Wang, C-P. & Mortensen, E.M. 2015. Statins and new-onset diabetes mellitus and diabetic complications: a retrospective cohort study of us healthy adults. Journal of General Internal Medicine 30(11):1599-1610.
742
Sokalska, A., Anderson, M., Villanueva, J., Ortega, I., Bruner-Tran, K.L., Osteen, K.G. & uleba, J.A. 2013. Effects of simvastatin on retinoic acid system in primary human endometrial stromal cells and in a chimeric model of human endometriosis. Journal of Clinical Endocrinology & Metabolism 98(3):E463-E471.
743
Blackwood, DP., LaVallee, RK., Al Busaidi, A., Jassal, DS. & Pierce, GN. 2015. A randomized trial of the effects of ezetimibe on the absorption of omega-3 fatty acids in cardiac disease patients: a pilot study. Clinical Nutrition ESPEN 10:e155-e159.
744
Lee, B-J., Tseng, Y-F., Yen, C-H. & Lin, P-T. 2013. Effects of coenzyme q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial. Nutrition Journal 12:142-151.
745
Banach, M., Serban, C., Ursoniu, S., Rusz, J., Muntner, P., Toth, P.P., Jones, S.R., Rizzo, M., Glasser, S.P., Watts, G.F., Blumenthal, R.S., Lip, G.Y.H., Mikhailidis, D.P., Sahebkar, A., Lipid and Blood Pressure Meta-analysis Collaboration Group. 2015. Statin therapy and plasma coenzyme q10 concentrations - a systematic review and meta-analysis of placebo-controlled trials. Pharmacological Research 99:329-336.
746
Ay, SA., Karaman, M., Cakar, M., Balta, S., Arslan, E., Bulucu, F., Demirbas, S., Celik, T., Naharci, MI., Demirkol, S., Kurt. O. & Bozoglu, E. 2013. Amlodipine increases vitamin D levels more than valsartan in newly diagnosed hypertensive patients: pointing to an additional effect on bone metabolism or a novel marker of inflammation? Renal Failure 35(5):601-696.
747
Braun, LA. & Rosenfeldt, F. 2013. Pharmaco-nutrient interactions - a systematic review of zinc and antihypertensive therapy. The International Journal of Clinical Practice 67(8):717-725.
748
Wilson, C.P., Ward, M., McNulty, H., Strain, J.J., Trouton, T.G., Horigan, G., Purvis, J. & Scott, J.M. 2012. Riboflavin offers a targeted strategy for managing hypertension in patients with the mthfr 677tt genotype: a 4-y follow up. American Journal of Clinical Nutrition 95:766-772.
749
Wilson, C.P., McNulty, H., Ward, M., Strain, J.J., Tourton, T.G., Hoeft, B.A., Weber, P., Roos, F.F., Horigan, G., McAnena, L. & Scott, J.M. 2013. Blood pressure in treated hypertensive individuals with the mthfr 677tt genotype is responsive to intervention with riboflavin. Hypertension 61:1302-1308.
750
Scheer, F.A.J.L., Morris, C.J., Garcia, J.I., Smales, C., Kelly, E.E., Marks, J., Malhotra, A. & Shea, S.A. 2012. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial. Sleep 35(10):1395-1402.
751
Yagi, T., Naito, T., Mino, Y., Umemura, K. & Kawakami, J. 2012. Impact of concomitant antacid administratin on bagapentin plasma exposure and oral bioavailability in healthy adult subjects. Drug Metabolism & Pharmacokinetics 27(2):248-254.
752
Quintero, GC. 2017. Review about gabapentin misuse, interactiomns, contraindications and side effects. Journal of Experimental Pharmacology 9:13-21.
753
Janiri, L., Martinotti, G., Tonioni, F., Ghelardini, C., Nicolai, R., Galeotti, N., Mosconi, L., Calvani, M., Bartolini, A. & Iannoni, E. 2009. Acetyl-l-carnitine in the management of pain during methadone withdrawal syndrome. Clinical Neuropharmacology 32(1):35-40.
754
Teigen, LM., Twernbold, DD. & Miller, WL. 2016. Prevalence of thiamine deficiency in a stable heart failure outpatient cohort on standard loop diuretic therapy. Clinical Nutrition 35:1323-1327.
755
Electronic Medicines Compendium. 2017. Product information – frumil. Datapharm. Accessed September 2017. https://www.medicines.org.uk/emc/medicine/25801
756
Hwant, KS. & Kim, G-H. 2010. Thiazide-induced hyponatremia. Electrolyte Blood Press 8:51-57.
757
Cohen, DL. & Townsend, RR. 2012. Hyponatremia and thiazides. The Journal of Clinical Hypertension 14(9):653.
758
Kwakernaak, AJ., Krikken, JA., Binnenmars, SH., Visser, FW., Hemmelder, MH., Woittiez, A-J., Groen, H., Laverman, GD., Navis, G on behalf of the Holland Nephrology Study (HONEST) Group. 2014. Effects of sodium restriction and hydrochlorothiazide on raas blockade efficacy in diabetic nephropathy: a randomised clinical trial. Lancet Diabetes Endocrinology 2:385-395.
759
Mondal, S., Saha, I., Das, S., Ganguly, A., Ghosh, A. & Das, AK. 2012. Oral aripiprazole-induced severe hypoglycemia. Therapeutic Drug Monitor 34(3):245-248.
760
Bell, DSH. 2010. Metformin-induced vitamin b12 deficiency presenting as a peripheral neuropathy. Southern Medical Journal 103(3):265-267
761
Liu, Q., Li, S., Quan, H. & Li, J. 2014. Vitamin b12 status in metformin treated patients: systematic review. Plos One 9)6):e100379.
762
Akinlade, KS., Agbebaku, SO., Rahamon, SK. & Balogun, WO. 2015. Vitamin b12 levels in patients with type 2 diabetes mellitus on metformin. Annals of Ibadan Postgraduate Medicine 13(2):79-83
763
Aroda, VR., Edelstein, SL., Goldberg, RB., Knowler, WC., Marcovina, SM., Orchard, TJ., Bray, GA., Schade, DS., Temprosa, MG., White, NH., Crandall, JP. & the Diabetes Prevention Program Research Group. 2016. Long-term metformin use and vitamin b12 deficiency in the diabetes prevention program outcomes study. Journal of Clinical Endocrinology & Metabolism 101(4):1754-1761.
764
Zdilla, MJ. 2015. Metformin with either histamine h2-receptor antagonists or proton pump inhibitors: a polypharmacy recipe for neuropathy via vitamin b12 depletion. Clinical Diabetes 33(2):90-95
765
Kang, D., Ko, S-H., Lim, T-S., Ahn, Y-B. & Park, Y-M. 2014. Higher prevalence of metformin-induced vitamin b12 deficiency in sulfonylurea combination compared with insulin combinatin in patients with type 2 diabetes: a cross-sectional study. Plos One 9(10):e109878.
766
Ahmed, MA., Muntingh, G. & Rheeder, P. 2016. Vitamin b12 deficiency in metformin-treated type-2 diabetes patients, prevalence and association with peripheral neuropathy. BMC Pharmacology & Toxicology 17:44-54.
767
Zhang, Q, Li, S., Li, L., Li, Q., Ren, K., Sun, X. & Li, J. 2016. Metformin treatment and homocysteine: a systematic review and meta-analysis of randomized controlled trials. Nutrients 8:798-810.
768
Chapman, LE., Darling, AL. & Brown, JE. 2016. Association between metformin and vitamin b12 deficiency in patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes & Metabolism 42(5):316-327.
769
Damiao, CP., Rodrigues, AO., Pinheiro, MFMC., Filho, RAdC., Cardoso, GP., Taboada, GF. & Lima, GAB. 2016. Prevalence of vitamin b12 deficiency in type 2 diabetic patients using metformin: a cross-sectional study. Sao Paolo Medical Journal 134(6).
770
Esmaeilzadeh, S., Gholinezhad-Chari, M. & Ghadimi, R. 2017. The effect of metformin treatment on the serum levels of homocysteine, folic acid, and vitamin B12 in patients with polycystic ovary syndrome. Journal of Human Reproductive Science 10(2):95-101.
771
Mohammadi, M., Amini, M., Aminiorroay, A., Rezvanian, H., Kachuei, A., Siyavash, M., Saghand, S-R. & Afkhami-Ardekani, M. 2009. Effect of metformin and folic acid on plasma homocysteine level in type 2 diabetic patients. International Journal of Medicine & Medical Sciences 1(3):88-90.
772
Palomba, S., Falbo, A., Giallauria, F., Russo, T., Tolino, A., Zullo, F., Colao, A. & Orio, F. 2010. Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome. Diabetes Care 33(2):246-251.
773
Bailey, DG., Dresser, G. & Arnold, JMO. 2013. Grapefruit-medication interactions: forbidden fruit or avoidable consequences? Canadian Medical Association Journal 185(4):309-316.
774
Jeon, H., Jang, I-J., Lee, S., Ohashi, K., Kotegawa, T., Ieiri, I., Cho, J-Y., Yoon, SH., Shin, S-G., Yu, K-S. & Lim, KS. 2012. Apple juice greatly reduces systemic exposure to atenolol. British Journal of Clinical Pharmacology 75(1):172-179.
776
PBS Schedule, 2019. http://www.pbs.gov.au. Search term ferrous fumarate and folic acid. Accessed 2019.
777
eMIMS.com.au, 2019. emims.com.au. Accessed 2019.
778
ePharmacy, 2019. epharmacy.com.au. Search term ferrous sulfate and folic acid. Accessed 2019.
779
ePharmacy, 2019. epharmacy.com.au. Search term ferrous sulfate and vitamin C. Accessed 2019.
780
emc, 2019. Electronic Medicines Compendium: https://www.medicines.org.uk/emc/. Accessed 2019.
781
Banks, NF., Tomko, PM., Colquhoun, RJ., Muddle, TWD., Emerson, SR. and Jenkins, NDM. 2019. Genetic polymorphisms in adora2a and cyp1a2 influence caffeine's effect on postprandial glycaemia. Scientific Reports 9, Article number: 10532.
782
European Medicines Agency. 2017. Information for the package leaflet regarding fructose and sorbitol used as excipients in medicinal products for human use. EMA/CHMP/460886/2014. Committee for Human Medicinal Products (CHMP).
783
Forsgard, RA. 2019. Lactose digestion in humans: intestinal lactase appears to be constitutive whereas microbiome is adaptable. American Journal of Clinical Nutrition 110:273-279.
784
US FDA. 2019. Oseni. Accessed 2019. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022426s000lbl.pdf
785
Behan, LA., Sherlock, M., Moyles, P., Renshaw, O., Thompson, CJT., Orr, C., Holte, K., Salehmohamed, MR., Glynn, N., Tormey, W. & Thompson, CJ. 2015. Abnormal plasma sodium concentrations in patients treated with desmopressin for cranial diabetes insipidus: results of a long-term retrospective study. European Journal of Endrocrinology 172:243-250
786
Said, HM., Ortiz, A., Kumar, CK., Chatterjee, N., Dudeja, K. & Rubin, S. 1999. Transport of thiamine in human intestine; mechanism and regulation in intestinal epithelial cell model caco-2. American Journal of Physiology 277 (Cell Physiology 46):C645-C651.
787
Lemos, C., Faria, A., Meireles, M., Martel, F., Monteiro, R & Calhau, C. 2012. Thiamine is a substrate of organic cation transporters in Caco-2 cells. European Journal of Pharmacology 682:37-42.
788
Inazu, M. 2019. Functional expression of choline transporters in the blood-brain barrier. Nutrients 11:2265-2274.
789
Chu, X., Chan, GH. & Evers, R. 2017. Identification of endogenous biomarkers to predict the propensity of drug candidates to cause hepatic or renal transporter-mediated drug-drug interactions. Journal of Pharmaceutical Sciences 106:2357-2367
790
Godo, S., Yoshida, Y., Fujita, M., Kudo, D., Nomura, R., Shimokawa, H. & Kushimoto, S. 2017. The dramatic recovery of a potient with buguanide-associated severe lactic acidosis following thiamine supplementation. Internal Medicine 56:455-459.
791
Liang, X. & Giacomini, KM. 2017. Transporters involved in metformin pharmacokinetics and treatment response. Journal of Pharmaceutical Sciences 106:2245-2250.
792
Nakamichi, N., Shima, H., Asano, S., Ishimoto, T., Sugiura, T., Matsubara, K., Kusuhara, H., Sugiyama, Y., Sai, Y., Miyamoto, K-I., Tsuji, A. & Kato, Y. 2013. Involvement of carnitine/organic cation transporter octn1/slc22a4 in gastrointestinal absorption of metformin. Journal of Pharmaceutical Sciences 102(9):3407-3417.
793
Liang, X., Chien, H-C., Yee, SW., Giacomini, MM., Chen, EC., Piao, M., Hao, J., Twelves, J., Lepist, E-I., Ray, AS. & Giacomini, KM. 2015. Metformin is a substrate and inhibitor of the human thiamine transporter, thtr-2 (slc19a3). Molecular Pharmacology 12(12):4301-4310.
794
Berghuis, B., van der Palen, J., de Haan, G-J., Lindhout, D., Koeleman, BPC., Sander, JW. & The EpiPGX Consortium. 2017. Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy. Epilepsia 58(7):1227-1233.
795
Ortiz, T., Villanueva-Paz, M., Diaz-Parrado, E., Illanes, M., Fernandez-Rodriguez, A., Sanchez-Alcazar, JA. & de Miguel, M. 2017. Amitriptyline down-regulates coenzyme q10 biocynthesis in lung cancer cells. European Journal of Pharmacology 797:75-82.
796
Patsalos, PN., Zugman, M., Lake, C., James, A., Ratnaraj, N. & Sander, JW. 2017. Serum protein binding of 25 antiepileptic drugs in a routine clinical setting; a comparison of free non-protein-bound concentrations. Epilepsia 58(7):1234-1243.
797
Abdlekawy, KS., Donia, AM. & Elbarbry, F. 2017. Effects of grapefruit and pomegranate juices on the pharmacokinetic properties of dapoxetine and in healthy subjects. European Journal of Drug Metabolism and Pharmacokinetics 42:397-405.
798
Fernandez, H., Mohammed, HT. & Patel T. 2017. Vitamin D supplementation for bone health in adults with epilepsy. Epilepsia 59:885-896.
799
Hossain, T., Ghazipura, M., Reddy, V., Rivera, P. & Mukherjee, V. 2018. Desmopressin-induced severe hyponatremia with central pontine myelinolysis: a case report. Drug Safety 5:19
800
Achinger, SG., Arieff, AI., Kalantar-Zadeh, K. & Ayus, JC. 2014. Desmopressin acetate (ddavp)-associated hyponatremia and brain damage: a case series. Nephrology Dialysis Transplantation 29:2310-2315
801
Juul, KV., Malmberg, A., van der Meulen, E., Walle, JV. & Norgaard, JP. 2017. Low-dose desmopressin combined with serum sodium monitoring can prevent clinically significant hyponatraemia in patients treated for nocturia. BJU International 119:776-784
802
emc, 2020. Electronic Medicines Compendium: https://www.medicines.org.uk/emc/. Accessed 2020.
803
Srinivasan, M., Ahmad, L., Bhindi, R. & Allahwala, U. 2019. Amiodarone in the aged. Australian Prescriber 42(5):158-162.
804
2020. NPS. https:// www.nps.org.au. Accessed 2020.
805
Matsuyama, H., Matsuura, K., Ishikawa, H., Hirata, Y., Kato, N., Niwa, A., Narita, Y. & Tomimoto, H. 2018. Proposition of zinc supplementation during levodopa-carbidopa intestinal gel treatment. Brain & Behaviour 8:e01143.
806
Romagnolo, A., Merola, A., Artusi, C.A., Rizzone, M.G., Zibetti, M. & Lopiano, L. 2018. Levodopa-induced neuropathy: a systematic review. Movement Disorders Cinical Practice 6(2):96-103.
807
Rispoli, V., Simioni, V., Capone, J.G., andreasi, N.G., Preda, F., Sette, E., Tugnoli, V. & sensi, M. 2017. Peripheral neuropathy in 30 duodopa patients with vitamins B supplementation. Acta Neurology Scandinavia 136(6):660-667.
808
Loens, S., Chorbadzhieva, E., Kleimann, A., Dressler, D. & Schrader, C. 2017. Effects of levodopa/carbidopa intestinal gel versus oral levodopa/carbidopa on b vitamin levels and neuropathy. Brain & Behaviour 7:e00698.
809
Shittu, MO. & Afolami, OI. 2020 Improving the efficacy of chloroquine and hydroxychloroquine against sars-cov-2 may require zinc additives - a better synergy for future covid-19 clinical trials. Le Infezioni in Medicina 2:192-197
810
Xue, J., Moyer, A., Peng, B., Wu, J., Hannafon, BN. & Ding, W-Q. 2014. Chloroquine is a zinc ionophore. Plos One 9(10):e109180.
811
Kaushik, N., Subramani, C., Anang, S., Muthumohan, R., Shalimar, Nayak, B., Ranjith-Kumar, CT. & Surjit, M. 2017. Zinc salts block hepatitis e virus replication by inhibiting the activity of viral rna-dependent rna polymerase. Journal of Virology 91(21):e00754-17
812
Matsuo, H., Yokooji, T., Morita, H., Ooi, M., Urata, K., Ishil, K., Takahagi, S., Yanase, Y., Hiragun, T., Mihara, S. & Hide. M. 2013. Aspirin augments ige-mediated histamine release from human peripheral basophils via syk kinase activation. Allergology International 62:503-511.
813
Rossell-Camps, A., Zibetti, S., Perez-Esteban, G., Vila-Vidal, M., Ferres-Ramis, L. & Garcia-Teresa-Garcia, E. 2013. Histamine intolerance as a cause of chronic digestive complaints in pediatric patients. Revista Espanola de Enfermedades Digestivas 105:201-207.
814
Kohn, JB. 2014. Is there a diet for histamine intolerance? Journal of the Academy of Nutrition & Dietetics 114:1860.
815
Calderon-Ospina, C-A, Nava-Mesa, MO. & Ariza, CEA. 2019. Effect of combined diclofenac and b vitamins (thiamine, pyridoxine, and cyanocobalamin) for low back pain management; systematic review and meta-analysis. Pain Medicine doi: 10.1093/pm/pnz216.
816
Marquez, M., Gusman, S. & Soto, H. 2015. Systematic review on the use of diclofenac/b complex as an anti-inflammatory treatment with pain relief effect for patients with acute lower back pain. Journal of Pain & Relief 4(6):216.
817
Ponce-Monter, HA., Ortiz, MI., Garza-Hernandez, AF., Monroy-Maya, RM., Soto-Rios, M., Arrillo-Alarcon, L., Reyes-Garcia, G. & Fernandez-Martinez, E. 2012. Effect of diclofenac with b vitamins on the treatment of acute pain originated by lower-limb fracture and surgery. Pain Research & Treatment doi: 10.1155/2012/104782.
818
Chang, H-Y., Tang, F-Y., Chen, D-Y., Chih, H-M., Huang, S-T., Cheng, H-D., Lan, J-L. & Chiang, E-PP. 2013. Clinical use of cyclooxygenase inhibitors impairs vitamin b-6 metabolism. American Journal of Clinical Nutrition 98:1440-1449.
819
Par, GH., Kim, S., K, MS., Yu, YM., Kim, GH., Lee, JS. & Lee, E. 2019. The association between cephalosporin and hypoprothrombinemia: a systematic review and meta-anlysis. International Journal of Environmental Research & Public Health 16:3937; doi:10.3390/ijerph16203937
820
Liu, J., Liu, Y., Zhang, Q., Zheng, J., Niu, Y. & Wang X. 2019. Hypocoagulation induced by broad-spectrum antibiotics in extensive burn patients. Burns & Trauma 7:13.
821
Itagaki, H. & Hagino, T. 2019. Vitamin K deficiency-induced hemorrhagic shock after thoracentesis: a case report. BMC Gastroenterology 19:58.
822
Frankling, MH., Norlin, A-C., Hansen, S., Borgstrom, EW., Bergman, P. & Bjorkhem-Bergman, L. 2020. Are vitamin d3 tablets equally effectivein raising 2-25-hydroxyvitamin d concentrations? a post-hoc analysis of an observational strudy on immunodeficient patients. Nutrients 12, 1230; doi:10.3390/nu12051230
823
Angelakis, E., Oddoze, C. & Raoult, D. 2013. Vitamin d and prolonged treatment with photosensitivity-associated antibiotics. Antimicrobial Agents & Chemotherapy 57(12):6409-6410.
824
Miller, JW. 2018. Proton pump inhibitors, h2-receptor antagonists, metformin, and vitamin b-12 deficiency: clinical implications. bAdvances in Nutrition 9:511S-518S.
825
Nakamura, Y., Suzuki, T., Yoshida, T., Yamazaki, H. & Kato, H. 2017. Vitamin d and calcium are required during denosumab treatment in osteoporosis with rheumatoid arthritis. Nutrients 9:428; doi:10.3390/nu9050428.
826
Huntsberry, AM., Linnebur, SA. & Vejar, M. 2015. Hyponatremia after initiation and rechallenge with trimethoprim-sulfamethoxazole in an older adult. Clinical Interventions in Aging 10:1091-1096.
827
Nagasaki, K., Gomi, H., Ishioka, H., Taguchi, S., Takayashiki, N. & Kobayashi, H. 2020. Challenges in treatment of disseminated nocardiosis in an elderly patient with renal failure on corticosteroids: a case report. IDCases 20:e00755.
828
Takubo, M, Tanaka, S., Kushimoto, M., Ikeda, J., Ogawa, K., Suzuki, Y., Abe, M., Ishihara, H. & Fujishiro, M. 2020. Hyponatremia associatd with prophylactic low-dose trimethorprim during systemic corticosteroid therapy for aqp4-positive optic neuritis in a diabetic patient. Antibiotics 9, 201.
829
du Plooy, N. & Rayner, B. 2019. Life-threatening hyperkalemia due to trimethoprim in a patient treated for pneumocystis jirovecii pneumonia. South Africa Medical Journal 109(2):89-90.
830
Diribe, N. & Le, J. 2019. Trimithoprim/sulfamethoxazole-induced bradycardia, renal failure, av-node blockers, shock and hyperkalemia syndrome. Clinical Practice and Cases in Emergency Medicine 3(3):282-285
831
Khorvash, F,. Moeinzadeh, F., Saffaei, A. & Hakamifard, A. 2019. Trimethoprim-sulfamethoxazole induced hypornatremia and hyperkalemia, the necessity of electrolyte follow-up in every patient. International Journal of Kidney Disease 13:277-280.
832
Prasad, BVR., Beckley, J., Mathur, M., Gunasekaran, M, Nash, MM., Rapi, L., Huang, M. & Zaltzman, JS. 2019. Safety and efficacy of prophylaxis for pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation. BMC Infectious Diseases 19:311.
833
Zhou, N. & Yang, C. 2019. A case of extreme hyponatremia without neurologic symptoms. Clinical Case Reports 7:1874-1879.
834
Gbinigie, O. 2018. Trimethoprim is associated with a greater risk of acute kidney injury and hyperkalaemia in older adults compared with other antibiotics used to treat utis. BMJ Evidence-Based Medicine 23(6):233.
835
Crellin, E., Mansfield, KE., Leyrat, C., Nitsch, D., Douglas, IJ., Root, A., Williamson, E., Smeeth, L. & Tomlinson. LA. 2018. Trimethoprim use for urinary tract infection and risk of advers outcomes in older patients: cohort study. BMJ 360:k341.
836
Mancano, MA. 2017. Ismp adverse drug reactions: allergic angina caused by fluconazole, rhabdomyolysis caused by risperidone, high incidence of hyponatremia with high-dose trimethoprim-sulfamethoxazole, lithium carbonate-induced hypersalivation, persistent hemorrhage after idarucizumab administration. Hospital Pharmacy 52(7):455-458.
837
Menegussi, J., Tatgiba, LS., Vianna, JGP., Seguro, AC. & Luchi, WM. 2018. A physiology-based approach to a patient with hyperkalemic renal tubular acidosis. Brazil Journal of Nephrology 40(4):410-417.
838
Haider, N. & Mazhar, F. 2020. Paliperidone-induced hyponatremia: report of a fatal case with analysis of cases reported in the literature and to the us food and drug adminisration adverse event reporting system (faers). Journal of the American College of Clinical Pharmacy 3:145
839
Medline Plus. https://medlineplus.gov/druginfo/meds. Accessed during 2020.
840
Mubarik, A., Kerndt, CC. & Cassagnol, M. 2020 StatPearls - Sotalol. https://www.ncbi.nlm.nih.gov/books/. Accessed 2020.
841
Medicines UK. Https://medicines.org.uk/emc/product. Accessed 2020.
842
South Australian Neonatal Medication Guidelines. 2020. Sotalol. https://www.sahealth.sa.gov.au. Search terms Sotalol and milk, dairy, calcium, potassium. Accessed 2020.
843
2020. https://gp2u.com.au Search term sotalol and milk, dairy, calcium, potassium. Accessed 2020.
844
2020. https:medicines.org.au. Accessed 2020.
845
Strickling, J. & Wilkowski, MJ. 2019. Severe, symptomatic hypocalcemia due to denosumab administration: treatment and clinical course. Case Reports in Nephrology & Dialysis9:33-41
846
Marlow, CF., Sharma, S., Babar, F. & Lin, J. 2018. Severe hypocalcemia and hypomagnesemia with denosumab in advanced chronic kidney disease: case report and literature review. Case Reports in Oncological Medicine 2018. doi.org/10.1155/2018/2059364.
847
Nakamura, Y., Suzuki, T., Kamimura, M., Murakami, K., Ikegami, S., Uchiyama, S. & Kato, H. 2017. Vitamin d and calcium are required at the time of denosumab administration during osteoporosis treatment. Bone Research 5:17021; doi:10.1038/boneres.2017.21.
848
Suzuki, T., Nakamura, Y. & Kato, H. 2017. Changes of bone-related minerals during denosumab administration in post-menopausal osteoporotic patients. Nutrients 9:871-879.
849
Sattar, A., Willman, JE. & Kolluri, R. 2013. Possible warfarin resistance due to interaction with ascorbic acid: case report and literature review. American Journal of Health System Pharmacy 70(9):782-786.
850
Yousef, GM. & Goebel, LJ. 2012. Vitamin C deficiency in an anticoagulated patient. Journal of General Intern Medicine 28(6):852-852.
851
George, BO. & Ojegbemi, O. 2009. Oxidative stress and the effect of riboflavin supplementation in individuals with uncomplicated malaria infection. African Journal of Biotechnology 8(5):849-853.
852
Suwannasom, N., Kao, I., Pruss, A., Georgieva, R. & Baumler, H. 2020. Riboflavin: the health benefits of a forgotten natural vitamin. International Journal of Molecular Sciences 21, 950; doi; 10.3390/ijms21030950.
853
Bernabe-Garcia, M., Lopez-Alarcon, M., Salgado-Sosa, A., Villegas-Silva, R., Maldonado-Hernandez, J., Rodriguez-Cruz, M., Rivas-Ruiz, R., Chavez-Sanchez, L., Blanco-Favela, FA., Mancilla-Ramirez, J., Gordillo-Alvarez, V. & Madrigal-Muniz, O. 2016. Enteral docosahexanoic acid reduces analgesic administration in neonates undergoing cardiovascular surgery. Annals of Nutrition & Metabolism 69:150-160.
854
Stott, KE., Singh, B., Beadsworth, MBJ., Vaudrey, K., Khoo, SH. & Davies, G. 2016. Adequacy of rifampin absorption after jejunostomy tube administration. Pharmacotherapy 36(4):e23-e25. doi: 10.1002/phar.1730
855
Lewis, J., Gregorian, T., Portillo, I. & Goad, J. 2019. Drug interactions with antimalarial medications in older travelers: a clinical guide. Journal of Travel Medicine 1-14, doi: 10.1093/jtm/taz089
856
US FDA. 2020. https://www.accessdata.fda.gov/. Accessed 2020.
857
Sixty Degrees Pharmaceuticals. 2018. Arakoda (tafenoquine succinate) tablets for the prevention of malaria in adults. Antimicrobial Drugs Advisory Committee Meeting -date 26th July 2018.
858
Sadler, JM., Ash, S. & Brito-Babapulle, FM. 2009. Possible fenugreek induced haemolysis in a patient with previously unknown g6pd deficiency. BMJ Case Reports. doi: 10.1136/bcr.09.2008.0895
859
Aksoy, D., Guveli, BT., Ak, PD., Sari, H., Atakli, D. & Arpaci, B. 2016. Effects of oxcarbazepine and levetiracetam on calcium, ionized calcium, and 25-oh vitamin d-3 levels in patients with epilepsy. Clinical Psychopharmacology & Neuroscience 14(1):74-78.
860
Aihara, S., Yamada, S., Kondo, M., Oka, H., Kamimura, T., Harada, A., Nakano, T., Tsuruya, K. & Kitazono, T. 2019. Severe hypocalemia and resulting seizure caused by vitamin d deficiency in an older patient receiving phenytoin: eldecalcitol and maxacalcitol ointment as potential therapueric options for hypocalcemia. Case Reports in Nephrology 2019. doi.org/10.1155/2019/3653276.
861
Dura-Trave, T., Gallinas-Victoriano, F., Malumbres-Chacon, M., Moreno-Gonzalez, P., Aguilera-Albesa, S. & Yoldi-Petri, ME. 2018. Vitamin d deficiency in children with epilepsy taking valproate and levetiracetam as monotherapy. Epilepsy Research 139:80-84.
862
Attilakos, A., Tsirouda, M., Dinopoulos, A. & Garoufi, A. 2018. Vitamin d status in children with epilepsy treated with levetiracetam monotherapy. Epilepsy Research 148:116.
863
Motomura, DIN., Cameron, PA. & Shetty, N. 2018. A curious case of hypercalcemia. Canadian Journal of General Internal Medicine 13(1):34-37.
864
Havens, PL., Stephensen, CB., van Loan, MD., Schuster, GU., Woodhouse, LR., Flynn, PM., Gordon, CM., Pan, CG., Rutledge, B., Harris, DR., Price, G., Baker, A., Meyer, WA., Wilson, CM., Hazra, R., Kapogiannis, BG. & Mulligan, K. 2018. Vitamin d3 supplementation increases spine bone mineral density in adolescents and young adults with human immunodeficiency virus infection being treated with tenofovir disoproxil fumarte: a randomized placebo-controlled trial. Clinical Infectious Diseases 66:220-228.
865
Amr, M., El-Mogy, A., Shams, T., Vieira, K. & Lakhan, SE. 2013. Efficacy of vitamin c as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double-blind, placebo-controlled pilot study. Nutrition Journal 12:31
866
Suliburska, J., Skrypnik, K., Szulinska, M., Kupsz, J., Markuszewski, L. & Bogdanski, P. 2018. Diuretics, ca-antagonists, and angiotensin-converting enzyme inhibitors affect zinc status in hypertensive patients on monotherapy: a randomized trial. Nutrients 10, 1284; doi:10.3390/nu10091284
867
Axton, ER., Cristobal, E., Choi, J., Miranda, CL. & Stevens, JF. 2018. Metabolomics-driven elucidation of cellular nitrate tolerance reveals ascorbic acid prevents nitroglycerin-induced inactivation of xanthine oxidase. Frontiers in Pharmacology 9, 1085; doi: 10.3389/fphar.2018.01085
868
Wegrzyn, NM. 2016. Malabsorption of l-t4 due to drip coffee: a case report using predictors of causation. Journal of the Academy of Nutrition and Dietetics 116(7):1073-1076.
869
Oliveira, KJ., Chiamolera, MI., Giannocco, G., Pazos-Moura, CC. & Ortiga-Carvalho, TM. 2019. Thyroid function disruptors: from nature to chemicals. Journal of Molecular Endocrinology 62:R1-R19.
870
Vora, B., Green EAE., Kjuri, N., Ballgren, F., Sirota, M. & Giacomini, KM. 2019. Drug-nutrient interactions: discovering prescription drug inhibitors of the thiamine transporter thtr-2 (slc19a3). American Journal of Clinical Nutrition doi:.org/10.1093/ajcn/nqz255.
871
Leitner, R., Zoernpfenning, E. & Missbichler, A. 2014. Evaluation of the inhibitory effect of various drugs / active ingredients on the activitiy of human diamine oxidase in vitro. Clinical and Translational Allergy 4(Suppl 3): 23.
872
Beltramo, E., Mazzeo, A., Lopatina, T., Trento, M. & Porta, M. 2020. Thiamine transporter 2 is involved in high glucose-induced damage and altered thiamine availability in cell models of diabetic retinopathy. Diabetes & Vascular Disease Research Jan-Feb: 1-15.
873
Liang, X. & Giacomini, KM. 2017. Transporters involved in metformin pharmacokinetics and treatment response. Journal of Pharmaceutical Sciences 106:2245-2250.
874
Solvo Biotechnology. 2020. solvobiotech.com/transporters/. Accessed 2020.
875
Giacomini, MM., Hao, J., Liang, X., Chandrasekhar, J., Twelves, J., Whitney, JA., Lepist, E-I. & Ray, AS. 2016. Interaction of 2,4-diaminopyrimidine-containing drugs including fedratinib and trimethoprim with thiamine transporters. Drug Metabolism & Disposition 45:76-85.
876
Nies, AT., Damme, K., Kruck, S., Schaeffeler E. & Schwab, M. 2016. Structure and function of multidrug and toxin extrusion proteins (mates) and their relevance to drug therapy and personalized medicine. Archives of Toxicology 90:1555-1584.
877
Lepist, E-I. & Ray, AS. 2016. Renal transporter-mediated drug-drug interactions: are they clinically relevant? The Journal of Clinical Pharmacology 56(S7):S73-S81.
878
Chen, EC., Khuri, N., Liang, X., Stecula, A., Chien, H-C., Yee, SW., Huang, Y., Sali, A. & Giacmini, KM. 2017. Discovery of competitive and noncompetitive ligands of the organic cation transporter 1 (oct1; slc22a1). bJournal of Medicinal Chemistry 60(7):2685-2696.
879
Meyer, MJ., Seitz, T., Brockmoller, J. & Tzvetkov, MV. 2017. Effects of genetic polymorphisms on the oct1 and oct2-mediated uptake of ranitidine. bPlos One 12(12):e0189521.
880
Hucke, A. & Ciarimboli, G. 2017. The role of transporters in the toxicity of chemotherapeutic drugs: focus on transporters for organic cations. bThe Journal of Clinical Pharmacoloy 56(S7):S157-S172.
881
Hyrsova, L., Smutny, T., Trejtnar, F. & Pavek, P. 2016. Expression of organic cation transporter 1 (oct1): unique patterns of indirect regulation by nuclear receptors and hepatospecific gene regulation. bDrug Metabolism Reviews 48(2):139-158.
882
Parvez, MM., Kaisar, N., Shin, HJ., Jung JA. & Shin, J-G. 2016. Inhibitory interaction potential of 22 antituberculosis drugs on organic anion and cation transporters of the slc22a family. bAntimicrobial Agents and Chemotherapy 60(11):6558-6567.
883
Koepsell, H. 2015. Role of organic cation transporters in drug-drug interaction. bExpert Opinion on Drug Metabolism & Toxicology 11(10):1-15.
884
Liang, Y., Li, S. & Chen, L. 2015. The physiological role of drug transporters. bProtein & Cell 6(5):334-350.
885
Dujic, T., Zhou, K., Donnelly, LA., Tavendale, R., Palmer, CNA. & Pearson, ER. 2015. Association of organic cation transporter 1 with intolerance to metformin in type 2 diabetes: a godarts study. bDiabetes 64:1786-1793.
886
Boxberger, KH., Hagenbuch, B. & Lampe, JN. 2014. Common drugs inhibit human organic cation transporter 1 (oct1)-mediated neurotransmitter uptake. bDrug Metabolism and Disposition 42:990-995.
887
Jeong, W., Doroshow, JH. & Kummar, S. 2013. US fda approved oral kinase inhibitors for the treatment of malignancies. bCurrent Problems in Cancer 37(3):110-144.
888
Giacomini, KM. 2016. The use of drug transporters as therapeutic targets. bAdvances in Drug Development 14(11):869-871.
889
Chen, L., Shu, Y., Liang, X., Chen, EC., Yee, SW., Zur, AA., Li, S., Xu, L., Keshari, KR., Lin, MJ., Chien, H-C., Zhang, Y., Morrissey, KM., Liu, J., Ostrem, J., Younger, NS., Kurhanewicz, J., Shokat, KM., Ashrafi, K. & Giacomini, KM. 2014. OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin. bPNAS 111(27):9983-9988.
890
Chen, L., Wah, SW. & Giacomini, KM. 2015. OCT1 in hepatic steatosis and thiamine disposition. bCell Cycle 14(3):283-284.
891
Nies, AT., Hofmann, U., Resch, C., Schaeffeler, E., Rius, M. & Schwab, M. 2011. Proton pump inhibitors inhibit metformin uptake by organic cation transporters (octs). bPlos One 6(7):e22163.
892
Personal Communication, 2020. OCT1 and thiamine. Email response from Professor KM Giacomini (ucsf.edu) to a list of questions regarding substrate and inhibitor impact on thiamine status.
893
Sandoval, PJ., Zorn, KM., Clark, AM., Ekins, S. & Wright, SH. 2018. Assessment of substrate-dependent ligand interactions at the organic cation transporter oct2 using six model substrates. bMolecular Pharmacology 94:1057-1068.
894
Hacker, K., Maas, R., Kornhuber, J., Fromm, MF. & Zolk, O. 2015. Substrate-dependent inhibition of the human organic cation transporter oct2: a comparison of metformin with experimental substrates. bPlos One 10(9):e0136451.
895
Yin, J. & Wang, J. 2016. Renal drug transporters and their significance in drug-drug interactions. bActa Pharmaceutica Sinica B 6(5):363-373.
896
Hussaarts, KGAM., Veerman, GDM., Jansman, FGA., van Gelder, T., Mathijssen, RHJ. & van Leeuwen, RWF. 2019. Clinically relevant drug interactions with multikinase inhibitors: a review. Therapeutic bAdvances in Medical Oncology 11:1-34.
897
Feng, B. & Varma, MV. 2016. Evaluation and quantitative prediction of renal transporter-mediated drug-drug interactions. bThe Journal of Clinical Pharmacology 56(S7):S110-S121.
898
Han, SY. & Choi, YH. 2020. Pharmacokinetic interaction between metformin and verapamil in rats: inhibition of the oct2-mediated renal excretion of metformin by verapamil. bPharmaceutics 12, 468; doi:10.3390/pharmaceutics12050468.
899
SHC, 2020. Straight Healthcare. www.straighthealthcare.com/organic-cation-transporter-1.html. Accessed 2020.
900
Sprowl, JA., Ong, SS., Gibson, AA., Hu, S., Du, G., Lin, W., Li, L., Bharill, S., Ness, RA., Stecula, A., Offer, SM., Diasio, RB., Nies, AT., Schwab, M., Cavaletti, G., Schlatter, E., Ciarimboli, G., Schellens, JHM., Isacoff, EY., Sali, A., Chen, T., Baker, SD., Sparreboom, A. & Pabla, N. 2016. A phosphotyrosine switch regulates organic cation transporters. bNature Communications 7:10880 doi: 0.1038/ncomms10880.
901
Nagashima, F., Nishiyama, R., Iwao, B., Kawai, Y., Ishii, C., Yamanaka, T., Uchino, H. & Inazu. M. 2018. Molecular and functional characterization of choline transporter-like proteins in esophageal cancer cells and potential therapeutic targets. bBiomolecules & Therapeutics 26(4):399-408.
902
Wagner, DJ., Hu, T. & Wang, J. 2016. Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics. bPharmacological Research 111:237-246
903
Jensen, O., Matthaei, J., Blome, F., Schwab, M., Tzvetkov, MV. & Brockmoller, J. 2020. Variability and heritability of thiamine pharmacokinetics with focus on oct1 effects on membrane transport and pharmacokinetics in humans. bClinical Pharmacology & Therapeutics 107(3):628-638.
904
Mayer, FP., Schmid, D., Owens, WA., Gould, GG., Apuschkin, M., Kudlacek, O., Salzer, I., Boehm, S., Chiba, P., Williams, PH., Wu, H-H., Gether, U., Koek, W., Daws, LC. & Sitte, HH. 2018. An unsuspected role for organic cation transporter 3 in the actions of amphetamine. bNeuropsychopharmacology 43:2408-2417.
905
ebs.tga.gov.au. 2018. Australian Register of Therapeutic Goods. www.ebs.tga.gov.au. Accessed during 2020.
906
Posada MM., Cannady, EA., Payne, CD., Zhang, X., Bacon, JA., Pak, YA., Higgins, JW., Shahri, N., Hall, SD. & Millgren, KM. 2017. Prediction of transporter-mediated drug-drug interactions for baricitinib. Clinical & Translational Science 10:509-519.
907
emc, 2021. Electronic Medicines Compendium: https://www.medicines.org.uk/emc/. Accessed 2021.
908
Alexander, SPH., Kelly, E., Mathie, A., Peters, JA., Veale, EL., Armstrong, JF., Faccenda, E., Harding, SD., Pawson, AJ., Sharman, JL., Southan, C., Davies, JA., CGTP Collaborators. 2019. The concise guide to pharmacology 2019/2020: transporters. bBritish Journal of Pharmacology 176(S1):S397-S493.
909
Bedoui, Y., Guillot, X., Selambarom, J., Guiraud, P., Giry, C,. Jaffar-Bandjee, MC., Ralandison, S. & Gasque, P. 2019. Methotrexate an old drug with new tricks. bInternational Journal of Molecular Sciences 20:5023
910
O'Connor, C., Wallace-Povirk, A., Ning, C., Fruhauf, J., Tong, N., Gangjee, A., Matherly, LH. & Hou, A. 2021. Folate transporter dynamics and therapy with classic and tumor-targeted antifolates. bScientific Reports 11:6389
911
Cline, A. & Jorizzo, JL. 2017. Does daily folic acid supplementatin reduce methotrexate efficacy? bDermatology Online Journal 23(11):6-8
912
Hino, H., Yang, M., Dalvi, P., Chen, T., Sun, L., Harper, PA. & Ito, S. 2020. In vitro effects of paclitaxel and cremophor el on human riboflavin transporter slc52a2. Biological and Pharmaceutical Bulletin 43:175-178.
913
Gelderblom, H., Verweij, J., Nooter, K. & Sparreboom, A. 2001. Cremophor el: the drawbacks and advantages of vehicle selection fro drug formulation. European Journal of Cancer 37:1590-1598.
914
emc, 2022. Electronic Medicines Compendium: https://www.medicines.org.uk/emc/. Accessed 2022.
915
2023. https:medicines.org.au. Accessed 2023.
916
emc, 2023. Electronic Medicines Compendium: https://www.medicines.org.uk/emc/. Accessed 2023.
917
US FDA. 2023. https://www.accessdata.fda.gov/. Accessed 2023.
918
European Medicines Agency. 2023. Accessed 2023.
919
Health Canada, 2023. https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html. Accessed 2023
© Copyright 2023. All rights reserved. This is an NCA Knowledge Product
We acknowledge the Aboriginal and Torres Strait Islander people as the Traditional Custodians of Country, and acknowledge and pay our respects to their Elders past, present and emerging.
